| 1 | BCMA-targeted CAR-T cell therapies in relapsed and/or refractory multiple myeloma: latest updates from 2023 ASCO Annual Meeting. (Wu JF, Dhakal B) J Hematol Oncol 2023 Jul 28;16(1):86 |
| 1 | The denominator in early phase CAR T-cell trials examining novel target antigens. (Abid MB) Lancet 2023 Jul 29;402(10399):354-356 |
| 1 | Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome. (Hines MR, Knight TE, McNerney KO, Leick MB, Jain T, Ahmed S, Frigault MJ, Hill JA, Jain MD, Johnson WT, Lin Y, Mahadeo KM, Maron GM, Marsh RA, Neelapu SS, Nikiforow S, Ombrello AK, Shah NN, Talleur AC, Turicek D, Vatsayan A, Wong SW, Maus MV, Komanduri KV, Berliner N, Henter JI, Perales MA, Frey NV, Teachey DT, Frank MJ, Shah NN) Transplant Cell Ther 2023 Jul;29(7):438.e1-438.e16 8 Citations |
| 1 | Characterizing T cell responses to enzymatically modified beta cell neo-epitopes. (Nguyen H, Arribas-Layton D, Chow IT, Speake C, Kwok WW, Hessner MJ, Greenbaum CJ, James EA) Front Immunol 2022;13:1015855 |
| 1 | T Cell-Depleted Peripheral Blood versus Unmanipulated Bone Marrow in Matched Sibling Transplantation for Aplastic Anemia. (Chorão P, Montoro J, Balaguer-Roselló A, Guerreiro M, Villalba M, Facal A, Solves P, Gómez-Segui I, Pasquini MC, Granados P, Bataller A, Louro A, de la Rubia J, Sanz MA, Sanz J) Transplant Cell Ther 2023 May;29(5):322.e1-322.e5 |
| 1 | Ethical Challenges with Multiple Myeloma BCMA Chimeric Antigen Receptor T Cell Slot Allocation: A Multi-Institution Experience. (Kourelis T, Bansal R, Berdeja J, Siegel D, Patel K, Mailankody S, Htut M, Shah N, Wong SW, Sidana S, Cowan AJ, Alsina M, Cohen A, Holstein SA, Bergsagel L, Ailawadhi S, Raje N, Dhakal B, Rossi A, Lin Y) Transplant Cell Ther 2023 Apr;29(4):255-258 6 Citations |
| 1 | Infectious Complications and Preventative Strategies following Chimeric Antigen Receptor T-cells (CAR-T cells) Therapy for B-Cell Malignancies. (Haroon A, Muhsen IN, Abid MB, Albabtain A, Alahmari A, Ahmed SO, Fakih RE, Aljurf M) Hematol Oncol Stem Cell Ther 2022 Nov 25;15(3):153-158 |
| 1 | Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group report. (Gossai NP, Devidas M, Chen Z, Wood BL, Zweidler-McKay PA, Rabin KR, Loh ML, Raetz EA, Winick NJ, Burke MJ, Carroll AJ, Esiashvili N, Heerema NA, Carroll WL, Hunger SP, Dunsmore KP, Winter SS, Teachey DT) Blood 2023 Apr 13;141(15):1802-1811 3 Citations |
| 2 | Detection of chromosomal alteration after infusion of gene-edited allogeneic CAR T cells. (Sasu BJ, Opiteck GJ, Gopalakrishnan S, Kaimal V, Furmanak T, Huang D, Goswami A, He Y, Chen J, Nguyen A, Balakumaran A, Shah NN, Hamadani M, Bone KM, Prashad S, Bowen MA, Pertel T, Embree HD, Gidwani SG, Chang D, Moore A, Leonard M, Amado RG) Mol Ther 2023 Mar 01;31(3):676-685 |
| 1 | Multispecific CAR T Cells Deprive Lymphomas of Escape via Antigen Loss. (Furqan F, Shah NN) Annu Rev Med 2023 Jan 27;74:279-291 4 Citations |
| 1 | Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells. (Goldman A, Raschi E, Chapman J, Santomasso BD, Pasquini MC, Perales MA, Shouval R) Blood 2023 Feb 09;141(6):673-677 1 Citation |
| 2 | Biobehavioral Implications of Chimeric Antigen Receptor T-cell Therapy: Current State and Future Directions. (Taylor MR, Steineck A, Lahijani S, Hall AG, Jim HSL, Phelan R, Knight JM) Transplant Cell Ther 2023 Jan;29(1):19-26 1 Citation |
| 4 | Associations between socioeconomic status and bispecific LV20.19 CAR T-cell therapy outcomes. (Knight JM, Hackett E, Szabo A, Wu R, Sauber G, Johnson B, Cusatis RN, Aughey E, Cole SW, Hillard CJ, Shah NN) Haematologica 2023 Feb 01;108(2):588-593 1 Citation |
| 1 | The druggable transcription factor Fli-1 regulates T cell immunity and tolerance in graft-versus-host disease. (Schutt SD, Wu Y, Kharel A, Bastian D, Choi HJ, Hanief Sofi M, Mealer C, McDaniel Mims B, Nguyen H, Liu C, Helke K, Cui W, Zhang X, Ben-David Y, Yu XZ) J Clin Invest 2022 Nov 01;132(21) 2 Citations |
| 4 | Long-term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20.19 CAR T-cells. (Zurko JC, Fenske TS, Johnson BD, Bucklan D, Szabo A, Xu H, Chaney K, Hamadani M, Hari P, Shah NN) Am J Hematol 2022 Dec;97(12):1580-1588 3 Citations |
| 1 | Conglomeration of T- and B-Cell Matrix Responses Determines the Potency of Human Bone Marrow Mesenchymal Stromal Cells. (Porter AP, Pirlot BM, Dyer K, Uwazie CC, Nguyen J, Turner C, Rajan D, Hematti P, Chinnadurai R) Stem Cells 2022 Dec 31;40(12):1134-1148 3 Citations |
| 1 | A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen × CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma. (D'Souza A, Shah N, Rodriguez C, Voorhees PM, Weisel K, Bueno OF, Pothacamury RK, Freise KJ, Yue S, Ross JA, Polepally AR, Talati C, Lee S, Jin Z, Buelow B, Vij R, Kumar S) J Clin Oncol 2022 Nov 01;40(31):3576-3586 24 Citations |
| 1 | T Cell-Specific STAT1 Expression Promotes Lytic Replication and Supports the Establishment of Gammaherpesvirus Latent Reservoir in Splenic B Cells. (Sylvester PA, Jondle CN, Schmalzriedt DL, Dittel BN, Tarakanova VL) mBio 2022 Aug 30;13(4):e0210722 |
| 1 | Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against FLT3- mutant acute myeloid leukemia and KMT2A-rearranged acute lymphoblastic leukemia. (Niswander LM, Graff ZT, Chien CD, Chukinas JA, Meadows CA, Leach LC, Loftus JP, Kohler ME, Tasian SK, Fry TJ) Haematologica 2023 Feb 01;108(2):457-471 4 Citations |
| 2 | Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium. (Stefanski HE, Eaton A, Baggott C, Rossoff J, Verneris MR, Prabhu S, Pacenta HL, Phillips CL, Talano JA, Moskop A, Margossian SP, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski MC, Keating AK, Wilcox R, Rabik CA, Fabrizio VA, Chinnabhandar V, Goksenin AY, Curran KJ, Mackall CL, Laetsch TW, Schultz LM) Blood Adv 2023 Feb 28;7(4):541-548 13 Citations |
| 1 | Role of CD19 Chimeric Antigen Receptor T Cells in Second-Line Large B Cell Lymphoma: Lessons from Phase 3 Trials. An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. (Perales MA, Anderson LD Jr, Jain T, Kenderian SS, Oluwole OO, Shah GL, Svoboda J, Hamadani M) Transplant Cell Ther 2022 Sep;28(9):546-559 9 Citations |
| 1 | T Cell-Intrinsic Interleukin 17 Receptor A Signaling Supports the Establishment of Chronic Murine Gammaherpesvirus 68 Infection. (Jondle CN, Tarakanova VL) J Virol 2022 Jul 27;96(14):e0063922 |
| 1 | Bispecific CAR T-cells for B-cell Malignancies. (Furqan F, Shah NN) Expert Opin Biol Ther 2022 Aug;22(8):1005-1015 3 Citations |
| 2 | Bispecific targeting of CD20 and CD19 increases polyfunctionality of chimeric antigen receptor T-cell products in B-cell malignancies. (Zurko JC, Xu H, Chaney K, Schneider D, Szabo A, Hari P, Johnson BD, Shah NN) Cytotherapy 2022 Aug;24(8):767-773 4 Citations |
| 1 | Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK pathway. (Sofi MH, Tian L, Schutt S, Khan I, Choi HJ, Wu Y, Bastian D, Ticer T, Kassir MF, Atilgan FC, Kim J, Sui X, Zivkovic A, Mehrotra S, O'Bryan JP, Stark H, Martin PJ, Ogretmen B, Yu XZ) Leukemia 2022 Jul;36(7):1907-1915 7 Citations |
| 1 | Autologous, lentivirus-modified, T-rapa cell "micropharmacies" for lysosomal storage disorders. (Nagree MS, Felizardo TC, Faber ML, Rybova J, Rupar CA, Foley SR, Fuller M, Fowler DH, Medin JA) EMBO Mol Med 2022 Apr 07;14(4):e14297 3 Citations |
| 5 | Tumor Derived Extracellular Vesicles Drive T Cell Exhaustion in Tumor Microenvironment through Sphingosine Mediated Signaling and Impacting Immunotherapy Outcomes in Ovarian Cancer. (Gupta P, Kadamberi IP, Mittal S, Tsaih SW, George J, Kumar S, Vijayan DK, Geethadevi A, Parashar D, Topchyan P, McAlarnen L, Volkman BF, Cui W, Zhang KYJ, Di Vizio D, Chaluvally-Raghavan P, Pradeep S) Adv Sci (Weinh) 2022 May;9(14):e2104452 16 Citations |
| 1 | Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma. (Teachey DT, Devidas M, Wood BL, Chen Z, Hayashi RJ, Hermiston ML, Annett RD, Archer JH, Asselin BL, August KJ, Cho SY, Dunsmore KP, Fisher BT, Freedman JL, Galardy PJ, Harker-Murray P, Horton TM, Jaju AI, Lam A, Messinger YH, Miles RR, Okada M, Patel SI, Schafer ES, Schechter T, Singh N, Steele AC, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay P, Bollard CM, Loh ML, Hunger SP, Raetz EA) J Clin Oncol 2022 Jul 01;40(19):2106-2118 28 Citations |
| 1 | Granulocyte Colony-Stimulating Factor Usage in Recipients of Chimeric Antigen Receptor T-Cell Immunotherapy. (Abid MB) J Clin Oncol 2022 May 01;40(13):1508-1509 2 Citations |
| 7 | Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients. (Abid MB, Rubin M, Ledeboer N, Szabo A, Longo W, Mohan M, Shah NN, Fenske TS, Abedin S, Runaas L, D'Souza A, Chhabra S, Dhakal B, Hamadani M) Cancer Cell 2022 Apr 11;40(4):340-342 24 Citations |
| 2 | Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails. (Brandum EP, Jørgensen AS, Calvo MB, Spiess K, Peterson FC, Yang Z, Volkman BF, Veldkamp CT, Rosenkilde MM, Goth CK, Hjortø GM) Int J Mol Sci 2022 Jan 26;23(3) 3 Citations |
| 1 | Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era. (Abid MB) Lancet Oncol 2022 Jan;23(1):16-18 2 Citations |
| 2 | Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice. (Wu Y, Fu J, Wang H, Yu XZ) Front Immunol 2021;12:778996 3 Citations |
| 1 | Translational Clinical Strategies for the Prevention of Gastrointestinal Tract Graft Versus Host Disease. (Rayasam A, Drobyski WR) Front Immunol 2021;12:779076 |
| 1 | Unrelated donor α/β T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemia. (Leahy AB, Li Y, Talano JA, Elgarten CW, Seif AE, Wang Y, Johnson B, Monos DS, Kadauke S, Olson TS, Freedman J, Wray L, Grupp SA, Bunin N) Blood Adv 2022 Feb 22;6(4):1175-1185 4 Citations |
| 1 | Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion. (Sun X, Wu B, Chiang HC, Deng H, Zhang X, Xiong W, Liu J, Rozeboom AM, Harris BT, Blommaert E, Gomez A, Garcia RE, Zhou Y, Mitra P, Prevost M, Zhang D, Banik D, Isaacs C, Berry D, Lai C, Chaldekas K, Latham PS, Brantner CA, Popratiloff A, Jin VX, Zhang N, Hu Y, Pujana MA, Curiel TJ, An Z, Li R) Nature 2021 Nov;599(7886):673-678 82 Citations |
| 1 | T cell receptor-targeted immunotherapeutics drive selective in vivo HIV- and CMV-specific T cell expansion in humanized mice. (Li M, Garforth SJ, O'Connor KE, Su H, Lee DM, Celikgil A, Chaparro RJ, Seidel RD, Jones RB, Arav-Boger R, Almo SC, Goldstein H) J Clin Invest 2021 Dec 01;131(23) 4 Citations |
| 2 | Promise and pitfalls of allogeneic chimeric antigen receptor therapy in plasma cell and lymphoid malignancies. (Dhakal B, Chhabra S, Savani BN, Hamadani M) Br J Haematol 2022 Apr;197(1):28-40 6 Citations |
| 1 | Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model? (Palen K, Zurko J, Johnson BD, Hari P, Shah NN) Cytotherapy 2021 Nov;23(11):985-990 5 Citations |
| 1 | DGKζ exerts greater control than DGKα over CD8+ T cell activity and tumor inhibition. (Gu J, Wang C, Cao C, Huang J, Holzhauer S, Desilva H, Wesley EM, Evans DB, Benci J, Wichroski M, Wee S, Riese MJ) Oncoimmunology 2021;10(1):1941566 3 Citations |
| 6 | Dietary Sodium Restriction Results in Tissue-Specific Changes in DNA Methylation in Humans. (Kidambi S, Pan X, Yang C, Liu P, Roberts ML, Li Y, Wang T, Laud PW, Liu Y, Rubens M, Thomas R, Widlansky ME, Beyer AM, Liu Y, Cowley AW Jr, Kotchen TA, Munyura Y, Moosreiner A, Mattson DL, Liang M) Hypertension 2021 Aug;78(2):434-446 5 Citations |
| 1 | Blueprint for the discovery of biomarkers of toxicity and efficacy for CAR T cells and T-cell engagers. (Paczesny S, Pasquini MC, Pavletic SZ, Agarwal A, Spellman S, Kean L, Bernatchez C, Gust J, Staedtke V, Perales MA) Blood Adv 2021 Jun 08;5(11):2519-2522 9 Citations |
| 1 | The Roseoloviruses Downregulate the Protein Tyrosine Phosphatase PTPRC (CD45). (Whyte ML, Smith KA, Buchberger A, Berg Luecke L, Tjan LH, Mori Y, Gundry RL, Hudson AW) J Virol 2021 Jun 24;95(14):e0162820 4 Citations |
| 1 | Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T cell response. (Vaena S, Chakraborty P, Lee HG, Janneh AH, Kassir MF, Beeson G, Hedley Z, Yalcinkaya A, Sofi MH, Li H, Husby ML, Stahelin RV, Yu XZ, Mehrotra S, Ogretmen B) Cell Rep 2021 May 04;35(5):109076 22 Citations |
| 1 | Interleukin-23 receptor signaling by interleukin-39 potentiates T cell pathogenicity in acute graft-versus-host disease. (Bastian D, Sui X, Nguyen HD, Wu Y, Schutt S, Tian L, Sofi MH, Liu Y, Martin P, Bartee E, Yu XZ) Am J Transplant 2021 Nov;21(11):3538-3549 9 Citations |
| 1 | Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations. (Abid MB) J Immunother Cancer 2021 Apr;9(4) 7 Citations |
| 1 | Clonally Focused Public and Private T Cells in Resected Brain Tissue From Surgeries to Treat Children With Intractable Seizures. (Chang JW, Reyes SD, Faure-Kumar E, Lam SK, Lawlor MW, Leventer RJ, Lew SM, Lockhart PJ, Pope K, Weiner HL, Salamon N, Vinters HV, Mathern GW, Fallah A, Owens GC) Front Immunol 2021;12:664344 3 Citations |
| 3 | PD-1 blockade after bispecific LV20.19 CAR T modulates CAR T-cell immunophenotype without meaningful clinical response. (Zurko J, Chaney K, Astle JM, Johnson BD, Hari P, Shah NN) Haematologica 2021 Oct 01;106(10):2788-2790 3 Citations |
| 1 | Emerging therapies for inv(16) AML. (Surapally S, Tenen DG, Pulikkan JA) Blood 2021 May 13;137(19):2579-2584 6 Citations |
| 1 | Investigations on T cell transmigration in a human skin-on-chip (SoC) model. (Ren X, Getschman AE, Hwang S, Volkman BF, Klonisch T, Levin D, Zhao M, Santos S, Liu S, Cheng J, Lin F) Lab Chip 2021 Apr 20;21(8):1527-1539 22 Citations |
| 1 | Neutrophil-Derived Myeloperoxidase Facilitates Both the Induction and Elicitation Phases of Contact Hypersensitivity. (Strzepa A, Gurski CJ, Dittel LJ, Szczepanik M, Pritchard KA Jr, Dittel BN) Front Immunol 2020;11:608871 9 Citations |
| 1 | A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD. (Sofi MH, Wu Y, Ticer T, Schutt S, Bastian D, Choi HJ, Tian L, Mealer C, Liu C, Westwater C, Armeson KE, Alekseyenko AV, Yu XZ) JCI Insight 2021 Feb 08;6(3) 31 Citations |
| 1 | Expression of GM-CSF Is Regulated by Fli-1 Transcription Factor, a Potential Drug Target. (Wang X, Lennard Richard M, Li P, Henry B, Schutt S, Yu XZ, Fan H, Zhang W, Gilkeson G, Zhang XK) J Immunol 2021 Jan 01;206(1):59-66 9 Citations |
| 1 | A Primer on Chimeric Antigen Receptor T-cell Therapy: What Does It Mean for Pathologists? (Cushman-Vokoun AM, Voelkerding KV, Fung MK, Nowak JA, Thorson JA, Duncan HL, Kalicanin T, Anderson MW, Yohe S) Arch Pathol Lab Med 2021 Jun 01;145(6):704-716 1 Citation |
| 2 | Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source. (Hess NJ, Lindner PN, Vazquez J, Grindel S, Hudson AW, Stanic AK, Ikeda A, Hematti P, Gumperz JE) Front Immunol 2020;11:573406 14 Citations |
| 1 | The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker. (Jardim DL, Goodman A, de Melo Gagliato D, Kurzrock R) Cancer Cell 2021 Feb 08;39(2):154-173 314 Citations |
| 4 | Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial. (Shah NN, Johnson BD, Schneider D, Zhu F, Szabo A, Keever-Taylor CA, Krueger W, Worden AA, Kadan MJ, Yim S, Cunningham A, Hamadani M, Fenske TS, Dropulić B, Orentas R, Hari P) Nat Med 2020 Oct;26(10):1569-1575 216 Citations |
| 8 | Severity of Cytokine Release Syndrome and Its Association with Infections after T Cell-Replete Haploidentical Related Donor Transplantation. (Abid MB, Hamadani M, Szabo A, Hari PN, Graham MB, Frank MO, Collier WS, Abedin S, Jerkins JH, Pasquini MC, Runaas L, Shah NN, Chhabra S) Biol Blood Marrow Transplant 2020 Sep;26(9):1670-1678 16 Citations |
| 2 | Early T Cell Activation Metrics Predict Graft-versus-Host Disease in a Humanized Mouse Model of Hematopoietic Stem Cell Transplantation. (Hess NJ, Hudson AW, Hematti P, Gumperz JE) J Immunol 2020 Jul 01;205(1):272-281 8 Citations |
| 3 | Intrathecal chemotherapy for management of steroid-refractory CAR T-cell-associated neurotoxicity syndrome. (Shah NN, Johnson BD, Fenske TS, Raj RV, Hari P) Blood Adv 2020 May 26;4(10):2119-2122 29 Citations |
| 3 | Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report. (Burroughs LM, Petrovic A, Brazauskas R, Liu X, Griffith LM, Ochs HD, Bleesing JJ, Edwards S, Dvorak CC, Chaudhury S, Prockop SE, Quinones R, Goldman FD, Quigg TC, Chandrakasan S, Smith AR, Parikh S, Dávila Saldaña BJ, Thakar MS, Phelan R, Shenoy S, Forbes LR, Martinez C, Chellapandian D, Shereck E, Miller HK, Kapoor N, Barnum JL, Chong H, Shyr DC, Chen K, Abu-Arja R, Shah AJ, Weinacht KG, Moore TB, Joshi A, DeSantes KB, Gillio AP, Cuvelier GDE, Keller MD, Rozmus J, Torgerson T, Pulsipher MA, Haddad E, Sullivan KE, Logan BR, Kohn DB, Puck JM, Notarangelo LD, Pai SY, Rawlings DJ, Cowan MJ) Blood 2020 Jun 04;135(23):2094-2105 69 Citations |
| 1 | Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML. (Bultitude WP, Schellekens J, Szydlo RM, Anthias C, Cooley SA, Miller JS, Weisdorf DJ, Shaw BE, Roberts CH, Garcia-Sepulveda CA, Lee J, Pearce RM, Wilson MC, Potter MN, Byrne JL, Russell NH, MacKinnon S, Bloor AJ, Patel A, McQuaker IG, Malladi R, Tholouli E, Orchard K, Potter VT, Madrigal JA, Mayor NP, Marsh SGE) Bone Marrow Transplant 2020 Oct;55(10):1975-1984 9 Citations |
| 1 | CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide. (Radhakrishnan SV, Luetkens T, Scherer SD, Davis P, Vander Mause ER, Olson ML, Yousef S, Panse J, Abdiche Y, Li KD, Miles RR, Matsui W, Welm AL, Atanackovic D) Nat Commun 2020 Feb 07;11(1):798 35 Citations |
| 3 | Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation? (Dreger P, Fenske TS, Montoto S, Pasquini MC, Sureda A, Hamadani M, European Society for Blood and Marrow Transplantation (EBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR)) Biol Blood Marrow Transplant 2020 Apr;26(4):e77-e85 34 Citations |
| 1 | Epigenetic Modifications in T Cells: The Role of DNA Methylation in Salt-Sensitive Hypertension. (Dasinger JH, Alsheikh AJ, Abais-Battad JM, Pan X, Fehrenbach DJ, Lund H, Roberts ML, Cowley AW Jr, Kidambi S, Kotchen TA, Liu P, Liang M, Mattson DL) Hypertension 2020 Feb;75(2):372-382 21 Citations |
| 1 | Beyond the Cell Surface: Targeting Intracellular Negative Regulators to Enhance T cell Anti-Tumor Activity. (Sitaram P, Uyemura B, Malarkannan S, Riese MJ) Int J Mol Sci 2019 Nov 20;20(23) 18 Citations |
| 1 | B Cell-Intrinsic SHP1 Expression Promotes the Gammaherpesvirus-Driven Germinal Center Response and the Establishment of Chronic Infection. (Johnson KE, Lange PT, Jondle CN, Volberding PJ, Lorenz UM, Cui W, Dittel BN, Tarakanova VL) J Virol 2019 Dec 12;94(1) 7 Citations |
| 3 | Dietary Effects on Dahl Salt-Sensitive Hypertension, Renal Damage, and the T Lymphocyte Transcriptome. (Abais-Battad JM, Alsheikh AJ, Pan X, Fehrenbach DJ, Dasinger JH, Lund H, Roberts ML, Kriegel AJ, Cowley AW Jr, Kidambi S, Kotchen TA, Liu P, Liang M, Mattson DL) Hypertension 2019 Oct;74(4):854-863 26 Citations |
| 1 | Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity. (Chakraborty P, Vaena SG, Thyagarajan K, Chatterjee S, Al-Khami A, Selvam SP, Nguyen H, Kang I, Wyatt MW, Baliga U, Hedley Z, Ngang RN, Guo B, Beeson GC, Husain S, Paulos CM, Beeson CC, Zilliox MJ, Hill EG, Mehrotra M, Yu XZ, Ogretmen B, Mehrotra S) Cell Rep 2019 Aug 13;28(7):1879-1893.e7 56 Citations |
| 1 | Radiation and host retinoic acid signaling promote the induction of gut-homing donor T cells after allogeneic hematopoietic stem cell transplantation. (Zheng J, Taylor B, Dodge J, Stephans A, Zheng SG, Chen Q, Chen X) Am J Transplant 2020 Jan;20(1):64-74 2 Citations |
| 1 | Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer. (Adashek JJ, Junior PNA, Galanina N, Kurzrock R) J Immunother Cancer 2019 May 22;7(1):130 7 Citations |
| 1 | Potency Analysis of Mesenchymal Stromal Cells Using a Phospho-STAT Matrix Loop Analytical Approach. (Chinnadurai R, Rajakumar A, Schneider AJ, Bushman WA, Hematti P, Galipeau J) Stem Cells 2019 Aug;37(8):1119-1125 20 Citations |
| 1 | Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease. (Sofi MH, Wu Y, Schutt SD, Dai M, Daenthanasanmak A, Heinrichs Voss J, Nguyen H, Bastian D, Iamsawat S, Selvam SP, Liu C, Maulik N, Ogretmen B, Jin J, Mehrotra S, Yu XZ) J Clin Invest 2019 May 02;129(7):2760-2774 23 Citations |
| 1 | Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells. (Chakraborty P, Chatterjee S, Kesarwani P, Thyagarajan K, Iamsawat S, Dalheim A, Nguyen H, Selvam SP, Nasarre P, Scurti G, Hardiman G, Maulik N, Ball L, Gangaraju V, Rubinstein MP, Klauber-DeMore N, Hill EG, Ogretmen B, Yu XZ, Nishimura MI, Mehrotra S) J Biol Chem 2019 Jun 07;294(23):9198-9212 23 Citations |
| 1 | A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma. (Lytle NK, Ferguson LP, Rajbhandari N, Gilroy K, Fox RG, Deshpande A, Schürch CM, Hamilton M, Robertson N, Lin W, Noel P, Wartenberg M, Zlobec I, Eichmann M, Galván JA, Karamitopoulou E, Gilderman T, Esparza LA, Shima Y, Spahn P, French R, Lewis NE, Fisch KM, Sasik R, Rosenthal SB, Kritzik M, Von Hoff D, Han H, Ideker T, Deshpande AJ, Lowy AM, Adams PD, Reya T) Cell 2019 Apr 18;177(3):572-586.e22 87 Citations |
| 1 | Inflammatory Cytokine Networks in Gastrointestinal Tract Graft vs. Host Disease. (Piper C, Drobyski WR) Front Immunol 2019;10:163 25 Citations |
| 2 | CD11c+ Cells Are Gatekeepers for Lymphocyte Trafficking to Infiltrated Islets During Type 1 Diabetes. (Sandor AM, Lindsay RS, Dyjack N, Whitesell JC, Rios C, Bradley BJ, Haskins K, Serreze DV, Geurts AM, Chen YG, Seibold MA, Jacobelli J, Friedman RS) Front Immunol 2019;10:99 19 Citations |
| 1 | A prospective multicenter observational study of cell-mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipients. (Kumar D, Chin-Hong P, Kayler L, Wojciechowski D, Limaye AP, Osama Gaber A, Ball S, Mehta AK, Cooper M, Blanchard T, MacDougall J, Kotton CN) Am J Transplant 2019 Sep;19(9):2505-2516 61 Citations |
| 1 | Modelling CAR-T therapy in humanized mice. (Wu Y, Yu XZ) EBioMedicine 2019 Feb;40:25-26 8 Citations |
| 1 | Chimeric antigen receptor modified T cell therapy in B cell non-Hodgkin lymphomas. (Levin A, Shah NN) Am J Hematol 2019 May;94(S1):S18-S23 18 Citations |
| 1 | The Role of Micronutrients in Graft-VS.-Host Disease: Immunomodulatory Effects of Vitamins A and D. (Chen X, Mayne CG) Front Immunol 2018;9:2853 6 Citations |
| 1 | Complement C3a and C5a receptors promote GVHD by suppressing mitophagy in recipient dendritic cells. (Nguyen H, Kuril S, Bastian D, Kim J, Zhang M, Vaena SG, Dany M, Dai M, Heinrichs JL, Daenthanasanmak A, Iamsawat S, Schutt S, Fu J, Wu Y, Fairlie DP, Atkinson C, Ogretmen B, Tomlinson S, Yu XZ) JCI Insight 2018 Dec 20;3(24) 19 Citations |
| 1 | Interferon-gamma production in Lyme arthritis synovial tissue promotes differentiation of fibroblast-like synoviocytes into immune effector cells. (Lochhead RB, Ordoñez D, Arvikar SL, Aversa JM, Oh LS, Heyworth B, Sadreyev R, Steere AC, Strle K) Cell Microbiol 2019 Feb;21(2):e12992 22 Citations |
| 1 | Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response. (Chatterjee S, Chakraborty P, Daenthanasanmak A, Iamsawat S, Andrejeva G, Luevano LA, Wolf M, Baliga U, Krieg C, Beeson CC, Mehrotra M, Hill EG, Rathmell JC, Yu XZ, Kraft AS, Mehrotra S) Clin Cancer Res 2019 Feb 01;25(3):1036-1049 28 Citations |
| 1 | Early Immunologic Response of Irreversible Electroporation versus Cryoablation in a Rodent Model of Pancreatic Cancer. (White SB, Zhang Z, Chen J, Gogineni VR, Larson AC) J Vasc Interv Radiol 2018 Dec;29(12):1764-1769 45 Citations |
| 1 | Lung γδ T Cells Mediate Protective Responses during Neonatal Influenza Infection that Are Associated with Type 2 Immunity. (Guo XJ, Dash P, Crawford JC, Allen EK, Zamora AE, Boyd DF, Duan S, Bajracharya R, Awad WA, Apiwattanakul N, Vogel P, Kanneganti TD, Thomas PG) Immunity 2018 Sep 18;49(3):531-544.e6 73 Citations |
| 1 | Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer. (Wu YM, Cieślik M, Lonigro RJ, Vats P, Reimers MA, Cao X, Ning Y, Wang L, Kunju LP, de Sarkar N, Heath EI, Chou J, Feng FY, Nelson PS, de Bono JS, Zou W, Montgomery B, Alva A, PCF/SU2C International Prostate Cancer Dream Team, Robinson DR, Chinnaiyan AM) Cell 2018 Jun 14;173(7):1770-1782.e14 339 Citations |
| 1 | Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency. (Boutboul D, Kuehn HS, Van de Wyngaert Z, Niemela JE, Callebaut I, Stoddard J, Lenoir C, Barlogis V, Farnarier C, Vely F, Yoshida N, Kojima S, Kanegane H, Hoshino A, Hauck F, Lhermitte L, Asnafi V, Roehrs P, Chen S, Verbsky JW, Calvo KR, Husami A, Zhang K, Roberts J, Amrol D, Sleaseman J, Hsu AP, Holland SM, Marsh R, Fischer A, Fleisher TA, Picard C, Latour S, Rosenzweig SD) J Clin Invest 2018 Jul 02;128(7):3071-3087 98 Citations |
| 1 | PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. (Daenthanasanmak A, Wu Y, Iamsawat S, Nguyen HD, Bastian D, Zhang M, Sofi MH, Chatterjee S, Hill EG, Mehrotra S, Kraft AS, Yu XZ) J Clin Invest 2018 Jul 02;128(7):2787-2801 24 Citations |
| 1 | B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation. (Miggelbrink AM, Logan BR, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Abdel-Azim H, Prockop SE, Shyr D, Decaluwe H, Hanson IC, Gillio A, Dávila Saldaña BJ, Eibel H, Hopkins G, Walter JE, Whangbo JS, Kohn DB, Puck JM, Cowan MJ, Griffith LM, Haddad E, O'Reilly RJ, Notarangelo LD, Pai SY) Blood 2018 Jun 28;131(26):2967-2977 31 Citations |
| 3 | Human IL12RB1 expression is allele-biased and produces a novel IL12 response regulator. (Reeme AE, Claeys TA, Aggarwal P, Turner AJ, Routes JM, Broeckel U, Robinson RT) Genes Immun 2019 Mar;20(3):181-197 4 Citations |
| 3 | Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models. (Tsai S, McOlash L, Palen K, Johnson B, Duris C, Yang Q, Dwinell MB, Hunt B, Evans DB, Gershan J, James MA) BMC Cancer 2018 Mar 27;18(1):335 227 Citations |
| 1 | Bowman capsulitis predicts poor kidney allograft outcome in T cell-mediated rejection. (Gallan AJ, Chon WJ, Josephson MA, Cunningham PN, Henriksen KJ, Chang A) Hum Pathol 2018 Jun;76:47-51 1 Citation |
| 1 | T-Cell Metabolism in Hematopoietic Cell Transplantation. (Nguyen HD, Kuril S, Bastian D, Yu XZ) Front Immunol 2018;9:176 25 Citations |
| 1 | Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation. (Betts BC, Bastian D, Iamsawat S, Nguyen H, Heinrichs JL, Wu Y, Daenthanasanmak A, Veerapathran A, O'Mahony A, Walton K, Reff J, Horna P, Sagatys EM, Lee MC, Singer J, Chang YJ, Liu C, Pidala J, Anasetti C, Yu XZ) Proc Natl Acad Sci U S A 2018 Feb 13;115(7):1582-1587 55 Citations |
| 1 | The structure, expression, and multifaceted role of immune-checkpoint protein VISTA as a critical regulator of anti-tumor immunity, autoimmunity, and inflammation. (Xu W, Hiếu T, Malarkannan S, Wang L) Cell Mol Immunol 2018 May;15(5):438-446 76 Citations |
| 2 | Elevated vasopressin in pregnant mice induces T-helper subset alterations consistent with human preeclampsia. (Scroggins SM, Santillan DA, Lund JM, Sandgren JA, Krotz LK, Hamilton WS, Devor EJ, Davis HA, Pierce GL, Gibson-Corley KN, Sigmund CD, Grobe JL, Santillan MK) Clin Sci (Lond) 2018 Feb 14;132(3):419-436 37 Citations |
| 1 | Hitting the Target: How T Cells Detect and Eliminate Tumors. (Zamora AE, Crawford JC, Thomas PG) J Immunol 2018 Jan 15;200(2):392-399 54 Citations |
| 1 | Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center. (Zhu F, Shah N, Xu H, Schneider D, Orentas R, Dropulic B, Hari P, Keever-Taylor CA) Cytotherapy 2018 Mar;20(3):394-406 63 Citations |
| 1 | CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response. (Chatterjee S, Daenthanasanmak A, Chakraborty P, Wyatt MW, Dhar P, Selvam SP, Fu J, Zhang J, Nguyen H, Kang I, Toth K, Al-Homrani M, Husain M, Beeson G, Ball L, Helke K, Husain S, Garrett-Mayer E, Hardiman G, Mehrotra M, Nishimura MI, Beeson CC, Bupp MG, Wu J, Ogretmen B, Paulos CM, Rathmell J, Yu XZ, Mehrotra S) Cell Metab 2018 Jan 09;27(1):85-100.e8 156 Citations |
| 2 | Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model. (Getschman AE, Imai Y, Larsen O, Peterson FC, Wu X, Rosenkilde MM, Hwang ST, Volkman BF) Proc Natl Acad Sci U S A 2017 Nov 21;114(47):12460-12465 43 Citations |
| 2 | T Cells Deficient in Diacylglycerol Kinase ζ Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia. (Jing W, Gershan JA, Holzhauer S, Weber J, Palen K, McOlash L, Pulakanti K, Wesley E, Rao S, Johnson BD, Riese MJ) Cancer Res 2017 Oct 15;77(20):5676-5686 14 Citations |
| 1 | Bioengineering Solutions for Manufacturing Challenges in CAR T Cells. (Piscopo NJ, Mueller KP, Das A, Hematti P, Murphy WL, Palecek SP, Capitini CM, Saha K) Biotechnol J 2018 Feb;13(2) 53 Citations |
| 1 | Variant histology, IgD and CD30 expression in low-risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: A report from the Children's Oncology Group. (Untanu RV, Back J, Appel B, Pei Q, Chen L, Buxton A, Hodgson DC, Ehrlich PF, Constine LS, Schwartz CL, Hutchison RE) Pediatr Blood Cancer 2018 Jan;65(1) 18 Citations |
| 2 | Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation. (Kharfan-Dabaja MA, Kumar A, Ayala E, Hamadani M, Reimer P, Gisselbrecht C, d'Amore F, Jantunen E, Ishida T, Bazarbachi A, Foss F, Advani R, Fenske TS, Lazarus HM, Friedberg JW, Aljurf M, Sokol L, Tobinai K, Tse E, Burns LJ, Chavez JC, Reddy NM, Suzuki R, Ahmed S, Nademanee A, Mohty M, Gopal AK, Fanale MA, Pro B, Moskowitz AJ, Sureda A, Perales MA, Carpenter PA, Savani BN) Biol Blood Marrow Transplant 2017 Nov;23(11):1826-1838 111 Citations |
| 1 | Increased Perfusion Pressure Drives Renal T-Cell Infiltration in the Dahl Salt-Sensitive Rat. (Evans LC, Petrova G, Kurth T, Yang C, Bukowy JD, Mattson DL, Cowley AW Jr) Hypertension 2017 Sep;70(3):543-551 51 Citations |
| 3 | Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide. (Bashey A, Zhang MJ, McCurdy SR, St Martin A, Argall T, Anasetti C, Ciurea SO, Fasan O, Gaballa S, Hamadani M, Munshi P, Al Malki MM, Nakamura R, O'Donnell PV, Perales MA, Raj K, Romee R, Rowley S, Rocha V, Salit RB, Solh M, Soiffer RJ, Fuchs EJ, Eapen M) J Clin Oncol 2017 Sep 10;35(26):3002-3009 211 Citations |
| 1 | T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model. (Woods DM, Woan KV, Cheng F, Sodré AL, Wang D, Wu Y, Wang Z, Chen J, Powers J, Pinilla-Ibarz J, Yu Y, Zhang Y, Wu X, Zheng X, Weber J, Hancock WW, Seto E, Villagra A, Yu XZ, Sotomayor EM) Blood 2017 Jul 13;130(2):146-155 51 Citations |
| 1 | Early mixed T-cell chimerism is predictive of pediatric AML or MDS relapse after hematopoietic stem cell transplant. (Broglie L, Helenowski I, Jennings LJ, Schafernak K, Duerst R, Schneiderman J, Tse W, Kletzel M, Chaudhury S) Pediatr Blood Cancer 2017 Sep;64(9) 8 Citations |
| 1 | LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases. (Qiao G, Qin J, Kunda N, Calata JF, Mahmud DL, Gann P, Fu YX, Rosenberg SA, Prabhakar BS, Maker AV) Cancer Res 2017 Apr 15;77(8):1880-1891 31 Citations |
| 1 | Effects of N-acetyl-seryl-asparyl-lysyl-proline on blood pressure, renal damage, and mortality in systemic lupus erythematosus. (Nakagawa P, Masjoan-Juncos JX, Basha H, Janic B, Worou ME, Liao TD, Romero CA, Peterson EL, Carretero OA) Physiol Rep 2017 Jan;5(2) 11 Citations |
| 1 | Dual Specificity Phosphatase 5 Is Essential for T Cell Survival. (Kutty RG, Xin G, Schauder DM, Cossette SM, Bordas M, Cui W, Ramchandran R) PLoS One 2016;11(12):e0167246 15 Citations |
| 1 | Cell-Intrinsic Barriers of T Cell-Based Immunotherapy. (Ghoneim HE, Zamora AE, Thomas PG, Youngblood BA) Trends Mol Med 2016 Dec;22(12):1000-1011 48 Citations |
| 2 | Effects of Donor Vitamin A Deficiency and Pharmacologic Modulation of Donor T Cell Retinoic Acid Pathway on the Severity of Experimental Graft-versus-Host Disease. (Dodge J, Stephans A, Lai J, Drobyski WR, Chen X) Biol Blood Marrow Transplant 2016 Dec;22(12):2141-2148 8 Citations |
| 7 | Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections. (Raj RV, Hari P, Pasquini M, Epperla N, D'Souza A, Fenske T, Shaw BE, Rizzo JD, Drobyski W, Hamadani M) Bone Marrow Transplant 2016 Dec;51(12):1602-1604 12 Citations |
| 1 | Engineering Hematopoietic Cells for Cancer Immunotherapy: Strategies to Address Safety and Toxicity Concerns. (Resetca D, Neschadim A, Medin JA) J Immunother 2016 Sep;39(7):249-59 7 Citations |
| 1 | Low-dose testosterone protects against renal ischemia-reperfusion injury by increasing renal IL-10-to-TNF-α ratio and attenuating T-cell infiltration. (Patil CN, Wallace K, LaMarca BD, Moulana M, Lopez-Ruiz A, Soljancic A, Juncos LA, Grande JP, Reckelhoff JF) Am J Physiol Renal Physiol 2016 Aug 01;311(2):F395-403 37 Citations |
| 2 | Development of GABAA Receptor Subtype-Selective Imidazobenzodiazepines as Novel Asthma Treatments. (Forkuo GS, Guthrie ML, Yuan NY, Nieman AN, Kodali R, Jahan R, Stephen MR, Yocum GT, Treven M, Poe MM, Li G, Yu OB, Hartzler BD, Zahn NM, Ernst M, Emala CW, Stafford DC, Cook JM, Arnold LA) Mol Pharm 2016 Jun 06;13(6):2026-38 24 Citations |
| 1 | Advances in understanding the pathogenesis of graft-versus-host disease. (Magenau J, Runaas L, Reddy P) Br J Haematol 2016 Apr;173(2):190-205 62 Citations |
| 1 | Antithymocyte globulin in allogeneic hematopoietic cell transplantation: benefits and limitations. (Nishihori T, Al-Kadhimi Z, Hamadani M, Kharfan-Dabaja MA) Immunotherapy 2016;8(4):435-47 25 Citations |
| 3 | The adhesion molecule PECAM-1 enhances the TGF-β-mediated inhibition of T cell function. (Newman DK, Fu G, Adams T, Cui W, Arumugam V, Bluemn T, Riese MJ) Sci Signal 2016 Mar 08;9(418):ra27 12 Citations |
| 1 | Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents. (Devata S, Wilcox RA) Am J Clin Dermatol 2016 Jun;17(3):225-37 25 Citations |
| 1 | T-bet Promotes Acute Graft-versus-Host Disease by Regulating Recipient Hematopoietic Cells in Mice. (Fu J, Wu Y, Nguyen H, Heinrichs J, Schutt S, Liu Y, Liu C, Jin J, Anasetti C, Yu XZ) J Immunol 2016 Apr 01;196(7):3168-79 6 Citations |
| 2 | Microdomains, Inflammation, and Atherosclerosis. (Sorci-Thomas MG, Thomas MJ) Circ Res 2016 Feb 19;118(4):679-91 121 Citations |
| 1 | Chimeric Antigen Receptor (CAR) therapy for multiple myeloma. (Atanackovic D, Radhakrishnan SV, Bhardwaj N, Luetkens T) Br J Haematol 2016 Mar;172(5):685-98 54 Citations |
| 1 | Dietary Vitamin D3 Suppresses Pulmonary Immunopathology Associated with Late-Stage Tuberculosis in C3HeB/FeJ Mice. (Reeme AE, Robinson RT) J Immunol 2016 Feb 01;196(3):1293-304 24 Citations |
| 1 | R-Ras Regulates Murine T Cell Migration and Intercellular Adhesion Molecule-1 Binding. (Yan X, Yan M, Guo Y, Singh G, Chen Y, Yu M, Wang D, Hillery CA, Chan AM) PLoS One 2015;10(12):e0145218 7 Citations |
| 2 | Emerging immunotherapy in pediatric lymphoma. (Erker C, Harker-Murray P, Burke MJ) Future Oncol 2016 Jan;12(2):257-70 3 Citations |
| 1 | In vitro testing of an anti-CD40 monoclonal antibody, clone 2C10, in primates and pigs. (Lee W, Satyananda V, Iwase H, Tanaka T, Miyagawa Y, Long C, Ayares D, Cooper DK, Hara H) Transpl Immunol 2015 Nov;33(3):185-91 7 Citations |
| 1 | Inhibitory effects of merocyanine 540-mediated photodynamic therapy on cellular immune functions: A role in the prophylaxis of graft-versus-host disease? (Traul DL, Sieber F) J Photochem Photobiol B 2015 Dec;153:153-63 13 Citations |
| 1 | Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer. (Das S, Rachagani S, Sheinin Y, Smith LM, Gurumurthy CB, Roy HK, Batra SK) Oncogene 2016 May 19;35(20):2645-54 49 Citations |
| 1 | MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice. (Wu Y, Heinrichs J, Bastian D, Fu J, Nguyen H, Schutt S, Liu Y, Jin J, Liu C, Li QJ, Xia C, Yu XZ) Blood 2015 Sep 10;126(11):1314-23 49 Citations |
| 2 | Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial. (Khera N, Majhail NS, Brazauskas R, Wang Z, He N, Aljurf MD, Akpek G, Atsuta Y, Beattie S, Bredeson CN, Burns LJ, Dalal JD, Freytes CO, Gupta V, Inamoto Y, Lazarus HM, LeMaistre CF, Steinberg A, Szwajcer D, Wingard JR, Wirk B, Wood WA, Joffe S, Hahn TE, Loberiza FR, Anasetti C, Horowitz MM, Lee SJ) Biol Blood Marrow Transplant 2015 Oct;21(10):1815-22 12 Citations |
| 1 | Repurposing a leukocyte elastase inhibitor for neuropathic pain. (Weyer AD, Stucky CL) Nat Med 2015 May;21(5):429-30 8 Citations |
| 1 | Absence of full-length neurokinin-1 receptor protein expression by cutaneous T cells: implications for substance P-mediated signaling in mycosis fungoides. (Tuzova M, Conniff T, Curiel-Lewandrowski C, Chaney K, Cruikshank W, Wolpowitz D) Acta Derm Venereol 2015 Sep;95(7):852-4 4 Citations |
| 1 | Mutation of SH2B3 (LNK), a genome-wide association study candidate for hypertension, attenuates Dahl salt-sensitive hypertension via inflammatory modulation. (Rudemiller NP, Lund H, Priestley JR, Endres BT, Prokop JW, Jacob HJ, Geurts AM, Cohen EP, Mattson DL) Hypertension 2015 May;65(5):1111-7 53 Citations |
| 1 | N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythematosus. (Liao TD, Nakagawa P, Janic B, D'Ambrosio M, Worou ME, Peterson EL, Rhaleb NE, Yang XP, Carretero OA) Am J Physiol Renal Physiol 2015 May 15;308(10):F1146-54 11 Citations |
| 2 | T-cell/histiocyte-rich large B-cell lymphoma in pediatric patients: an under-recognized entity? (Gheorghe G, Rangarajan HG, Camitta B, Segura A, Kroft S, Southern JF) Ann Clin Lab Sci 2015;45(1):73-8 4 Citations |
| 1 | Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation. (Radhakrishnan SV, Palaniyandi S, Mueller G, Miklos S, Hager M, Spacenko E, Karlsson FJ, Huber E, Kittan NA, Hildebrandt GC) Biol Blood Marrow Transplant 2015 Jan;21(1):30-8 16 Citations |
| 1 | Design of the INHIBIT trial: preventing inhibitors by avoiding 'danger', prolonging half-life and promoting tolerance. (Ragni MV, Malec LM) Expert Rev Hematol 2014 Dec;7(6):747-55 18 Citations |
| 1 | Caspase-8 polymorphisms result in reduced Alemtuzumab-induced T-cell apoptosis and worse survival after transplantation. (Shaw BE, Lee F, Krishnamurthy S, Byrne JL, Seedhouse C, Mayor NP, Maldonado-Torres H, Saudemont A, Marsh SG, Madrigal JA, Russell NH) Bone Marrow Transplant 2015 Feb;50(2):237-43 2 Citations |
| 1 | Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. (Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, Baker M, Ballow M, Bartoshesky LE, Bonilla FA, Brokopp C, Brooks E, Caggana M, Celestin J, Church JA, Comeau AM, Connelly JA, Cowan MJ, Cunningham-Rundles C, Dasu T, Dave N, De La Morena MT, Duffner U, Fong CT, Forbes L, Freedenberg D, Gelfand EW, Hale JE, Hanson IC, Hay BN, Hu D, Infante A, Johnson D, Kapoor N, Kay DM, Kohn DB, Lee R, Lehman H, Lin Z, Lorey F, Abdel-Mageed A, Manning A, McGhee S, Moore TB, Naides SJ, Notarangelo LD, Orange JS, Pai SY, Porteus M, Rodriguez R, Romberg N, Routes J, Ruehle M, Rubenstein A, Saavedra-Matiz CA, Scott G, Scott PM, Secord E, Seroogy C, Shearer WT, Siegel S, Silvers SK, Stiehm ER, Sugerman RW, Sullivan JL, Tanksley S, Tierce ML 4th, Verbsky J, Vogel B, Walker R, Walkovich K, Walter JE, Wasserman RL, Watson MS, Weinberg GA, Weiner LB, Wood H, Yates AB, Puck JM, Bonagura VR) JAMA 2014 Aug 20;312(7):729-38 512 Citations |
| 1 | Transplantation outcomes for severe combined immunodeficiency, 2000-2009. (Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Hanson IC, Filipovich AH, Jyonouchi S, Sullivan KE, Small TN, Burroughs L, Skoda-Smith S, Haight AE, Grizzle A, Pulsipher MA, Chan KW, Fuleihan RL, Haddad E, Loechelt B, Aquino VM, Gillio A, Davis J, Knutsen A, Smith AR, Moore TB, Schroeder ML, Goldman FD, Connelly JA, Porteus MH, Xiang Q, Shearer WT, Fleisher TA, Kohn DB, Puck JM, Notarangelo LD, Cowan MJ, O'Reilly RJ) N Engl J Med 2014 Jul 31;371(5):434-46 541 Citations |
| 1 | Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201. (Waller EK, Logan BR, Harris WA, Devine SM, Porter DL, Mineishi S, McCarty JM, Gonzalez CE, Spitzer TR, Krijanovski OI, Linenberger ML, Woolfrey A, Howard A, Wu J, Confer DL, Anasetti C) J Clin Oncol 2014 Aug 01;32(22):2365-72 71 Citations |
| 1 | Acute graft-versus-host disease: a bench-to-bedside update. (Holtan SG, Pasquini M, Weisdorf DJ) Blood 2014 Jul 17;124(3):363-73 154 Citations |
| 1 | CCR4+T cell recruitment to the skin in mycosis fungoides: potential contributions by thymic stromal lymphopoietin and interleukin-16. (Tuzova M, Richmond J, Wolpowitz D, Curiel-Lewandrowski C, Chaney K, Kupper T, Cruikshank W) Leuk Lymphoma 2015 Feb;56(2):440-9 18 Citations |
| 1 | Laboratory diagnosis of primary immunodeficiencies. (Locke BA, Dasu T, Verbsky JW) Clin Rev Allergy Immunol 2014 Apr;46(2):154-68 46 Citations |
| 1 | CD247 modulates blood pressure by altering T-lymphocyte infiltration in the kidney. (Rudemiller N, Lund H, Jacob HJ, Geurts AM, Mattson DL, PhysGen Knockout Program) Hypertension 2014 Mar;63(3):559-64 105 Citations |
| 1 | Pharmacologic inhibition of PKCα and PKCθ prevents GVHD while preserving GVL activity in mice. (Haarberg KM, Li J, Heinrichs J, Wang D, Liu C, Bronk CC, Kaosaard K, Owyang AM, Holland S, Masuda E, Tso K, Blazar BR, Anasetti C, Beg AA, Yu XZ) Blood 2013 Oct 03;122(14):2500-11 35 Citations |
| 1 | Pulmonary cytokine composition differs in the setting of alcohol use disorders and cigarette smoking. (Burnham EL, Kovacs EJ, Davis CS) Am J Physiol Lung Cell Mol Physiol 2013 Jun 15;304(12):L873-82 24 Citations |
| 1 | Human adipose-derived mesenchymal stem cells engineered to secrete IL-10 inhibit APC function and limit CNS autoimmunity. (Payne NL, Sun G, McDonald C, Moussa L, Emerson-Webber A, Loisel-Meyer S, Medin JA, Siatskas C, Bernard CC) Brain Behav Immun 2013 May;30:103-14 47 Citations |
| 1 | Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies. (Kindt N, Preillon J, Kaltner H, Gabius HJ, Chevalier D, Rodriguez A, Johnson BD, Megalizzi V, Decaestecker C, Laurent G, Saussez S) J Cancer Res Clin Oncol 2013 May;139(5):727-37 29 Citations |
| 1 | The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis. (Padgett LE, Broniowska KA, Hansen PA, Corbett JA, Tse HM) Ann N Y Acad Sci 2013 Apr;1281(1):16-35 216 Citations |
| 1 | Examining T cells at vaccine sites of tumor-bearing hosts provides insights to dysfunctional T-cell immunity. (Barr KM, Jing W, Hallett WH, Gershan JA, Johnson BD) J Immunother 2013 Jan;36(1):41-51 2 Citations |
| 2 | High density lipoprotein biogenesis, cholesterol efflux, and immune cell function. (Sorci-Thomas MG, Thomas MJ) Arterioscler Thromb Vasc Biol 2012 Nov;32(11):2561-5 80 Citations |
| 1 | Ataxia telangiectasia mutated kinase controls chronic gammaherpesvirus infection. (Kulinski JM, Leonardo SM, Mounce BC, Malherbe L, Gauld SB, Tarakanova VL) J Virol 2012 Dec;86(23):12826-37 29 Citations |
| 1 | The TCR repertoires of regulatory and conventional T cells specific for the same foreign antigen are distinct. (Relland LM, Williams JB, Relland GN, Haribhai D, Ziegelbauer J, Yassai M, Gorski J, Williams CB) J Immunol 2012 Oct 01;189(7):3566-74 22 Citations |
| 1 | p53 mediates TNF-induced epithelial cell apoptosis in IBD. (Goretsky T, Dirisina R, Sinh P, Mittal N, Managlia E, Williams DB, Posca D, Ryu H, Katzman RB, Barrett TA) Am J Pathol 2012 Oct;181(4):1306-15 79 Citations |
| 1 | The Nlrp3 inflammasome promotes age-related thymic demise and immunosenescence. (Youm YH, Kanneganti TD, Vandanmagsar B, Zhu X, Ravussin A, Adijiang A, Owen JS, Thomas MJ, Francis J, Parks JS, Dixit VD) Cell Rep 2012 Jan 26;1(1):56-68 110 Citations |
| 1 | LBH589 enhances T cell activation in vivo and accelerates graft-versus-host disease in mice. (Wang D, Iclozan C, Liu C, Xia C, Anasetti C, Yu XZ) Biol Blood Marrow Transplant 2012 Aug;18(8):1182-1190.e1 23 Citations |
| 2 | Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia. (Veys P, Wynn RF, Ahn KW, Samarasinghe S, He W, Bonney D, Craddock J, Cornish J, Davies SM, Dvorak CC, Duerst RE, Gross TG, Kapoor N, Kitko C, Krance RA, Leung W, Lewis VA, Steward C, Wagner JE, Carpenter PA, Eapen M) Blood 2012 Jun 21;119(25):6155-61 34 Citations |
| 1 | Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease. (Rangarajan H, Yassai M, Subramanian H, Komorowski R, Whitaker M, Gorski J, Drobyski WR) Blood 2012 Jun 28;119(26):6354-64 20 Citations |
| 1 | Annexin-V promotes anti-tumor immunity and inhibits neuroblastoma growth in vivo. (Yan X, Doffek K, Yin C, Krein M, Phillips M, Sugg SL, Johnson B, Shilyansky J) Cancer Immunol Immunother 2012 Nov;61(11):1917-27 13 Citations |
| 1 | Regulation of acute graft-versus-host disease by microRNA-155. (Ranganathan P, Heaphy CE, Costinean S, Stauffer N, Na C, Hamadani M, Santhanam R, Mao C, Taylor PA, Sandhu S, He G, Shana'ah A, Nuovo GJ, Lagana A, Cascione L, Obad S, Broom O, Kauppinen S, Byrd JC, Caligiuri M, Perrotti D, Hadley GA, Marcucci G, Devine SM, Blazar BR, Croce CM, Garzon R) Blood 2012 May 17;119(20):4786-97 120 Citations |
| 1 | Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. (Thu MS, Bryant LH, Coppola T, Jordan EK, Budde MD, Lewis BK, Chaudhry A, Ren J, Varma NR, Arbab AS, Frank JA) Nat Med 2012 Feb 26;18(3):463-7 173 Citations |
| 1 | Cell fate control gene therapy based on engineered variants of human deoxycytidine kinase. (Neschadim A, Wang JC, Sato T, Fowler DH, Lavie A, Medin JA) Mol Ther 2012 May;20(5):1002-13 18 Citations |
| 1 | Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients. (Clark RA, Watanabe R, Teague JE, Schlapbach C, Tawa MC, Adams N, Dorosario AA, Chaney KS, Cutler CS, Leboeuf NR, Carter JB, Fisher DC, Kupper TS) Sci Transl Med 2012 Jan 18;4(117):117ra7 286 Citations |
| 1 | The Wisconsin approach to newborn screening for severe combined immunodeficiency. (Verbsky J, Thakar M, Routes J) J Allergy Clin Immunol 2012 Mar;129(3):622-7 81 Citations |
| 1 | Higher infused CD34+ cell dose and overall survival in patients undergoing in vivo T-cell depleted, but not t-cell repleted, allogeneic peripheral blood hematopoietic cell transplantation. (Kanate AS, Craig M, Cumpston A, Saad A, Hobbs G, Leadmon S, Bunner P, Watkins K, Bulian D, Gibson L, Abraham J, Remick SC, Hamadani M) Hematol Oncol Stem Cell Ther 2011;4(4):149-56 5 Citations |
| 1 | T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome. (Weisdorf D, Cooley S, Devine S, Fehniger TA, DiPersio J, Anasetti C, Waller EK, Porter D, Farag S, Drobyski W, Defor T, Haagenson M, Curtsinger J, Miller J) Biol Blood Marrow Transplant 2012 Jun;18(6):937-43 23 Citations |
| 1 | Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells. (Brindley SM, Lanham AM, Karrer FM, Tucker RM, Fontenot AP, Mack CL) Hepatology 2012 Apr;55(4):1130-8 85 Citations |
| 2 | Newborn screening for severe combined immunodeficiency; the Wisconsin experience (2008-2011). (Verbsky JW, Baker MW, Grossman WJ, Hintermeyer M, Dasu T, Bonacci B, Reddy S, Margolis D, Casper J, Gries M, Desantes K, Hoffman GL, Brokopp CD, Seroogy CM, Routes JM) J Clin Immunol 2012 Feb;32(1):82-8 117 Citations |
| 1 | Screening newborns for primary T-cell immunodeficiencies: consensus and controversy. (Accetta Pedersen DJ, Verbsky J, Routes JM) Expert Rev Clin Immunol 2011 Nov;7(6):761-8 9 Citations |
| 1 | Neutrophils are required for 3-methylcholanthrene-initiated, butylated hydroxytoluene-promoted lung carcinogenesis. (Vikis HG, Gelman AE, Franklin A, Stein L, Rymaszewski A, Zhu J, Liu P, Tichelaar JW, Krupnick AS, You M) Mol Carcinog 2012 Dec;51(12):993-1002 20 Citations |
| 1 | BB rat Gimap gene expression in sorted lymphoid T and B cells. (Moralejo DH, Fuller JM, Rutledge EA, Van Yserloo B, Ettinger RA, Jensen R, Osborne W, Kwitek A, Lernmark A) Life Sci 2011 Nov 07;89(19-20):748-54 7 Citations |
| 1 | Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303. (Keever-Taylor CA, Devine SM, Soiffer RJ, Mendizabal A, Carter S, Pasquini MC, Hari PN, Stein A, Lazarus HM, Linker C, Goldstein SC, Stadtmauer EA, O'Reilly RJ) Biol Blood Marrow Transplant 2012 May;18(5):690-7 51 Citations |
| 1 | Juvenile dermatomyositis: immunopathogenesis, role of myositis-specific autoantibodies, and review of rituximab use. (Chiu YE, Co DO) Pediatr Dermatol 2011;28(4):357-67 36 Citations |
| 1 | Depletion of CD25⁺ T cells from hematopoietic stem cell grafts increases posttransplantation vaccine-induced immunity to neuroblastoma. (Jing W, Yan X, Hallett WH, Gershan JA, Johnson BD) Blood 2011 Jun 23;117(25):6952-62 37 Citations |
| 3 | Critical role for Gimap5 in the survival of mouse hematopoietic stem and progenitor cells. (Chen Y, Yu M, Dai X, Zogg M, Wen R, Weiler H, Wang D) J Exp Med 2011 May 09;208(5):923-35 32 Citations |
| 1 | Mouse Rankl expression is regulated in T cells by c-Fos through a cluster of distal regulatory enhancers designated the T cell control region. (Bishop KA, Coy HM, Nerenz RD, Meyer MB, Pike JW) J Biol Chem 2011 Jun 10;286(23):20880-91 46 Citations |
| 2 | Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies. (Soiffer RJ, Lerademacher J, Ho V, Kan F, Artz A, Champlin RE, Devine S, Isola L, Lazarus HM, Marks DI, Porter DL, Waller EK, Horowitz MM, Eapen M) Blood 2011 Jun 23;117(25):6963-70 296 Citations |
| 1 | Plasmin plays an essential role in amplification of psoriasiform skin inflammation in mice. (Li Q, Ke F, Zhang W, Shen X, Xu Q, Wang H, Yu XZ, Leng Q, Wang H) PLoS One 2011 Feb 02;6(2):e16483 30 Citations |
| 1 | 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. (Mayne CG, Spanier JA, Relland LM, Williams CB, Hayes CE) Eur J Immunol 2011 Mar;41(3):822-32 137 Citations |
| 2 | Human phagocyte defect caused by a Rac2 mutation detected by means of neonatal screening for T-cell lymphopenia. (Accetta D, Syverson G, Bonacci B, Reddy S, Bengtson C, Surfus J, Harbeck R, Huttenlocher A, Grossman W, Routes J, Verbsky J) J Allergy Clin Immunol 2011 Feb;127(2):535-538.e1-2 73 Citations |
| 1 | Ingested (oral) ACTH inhibits EAE. (Brod SA, Hood ZM) J Neuroimmunol 2011 Mar;232(1-2):131-5 21 Citations |
| 1 | Eosinophilic/T-cell chorionic vasculitis: a clinicopathologic and immunohistochemical study of 51 cases. (Jacques SM, Qureshi F, Kim CJ, Lee JH, Giorgadze T, Mittal P, Hassan SS, Romero R) Pediatr Dev Pathol 2011;14(3):198-205 32 Citations |
| 2 | Control of intestinal Nod2-mediated peptidoglycan recognition by epithelium-associated lymphocytes. (Duerr CU, Salzman NH, Dupont A, Szabo A, Normark BH, Normark S, Locksley RM, Mellroth P, Hornef MW) Mucosal Immunol 2011 May;4(3):325-34 24 Citations |
| 1 | Newborn screening for T-cell deficiency. (Chase NM, Verbsky JW, Routes JM) Curr Opin Allergy Clin Immunol 2010 Dec;10(6):521-5 18 Citations |
| 1 | Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease. (Driver JP, Serreze DV, Chen YG) Semin Immunopathol 2011 Jan;33(1):67-87 141 Citations |
| 3 | Phospholipase C{gamma}1 is essential for T cell development, activation, and tolerance. (Fu G, Chen Y, Yu M, Podd A, Schuman J, He Y, Di L, Yassai M, Haribhai D, North PE, Gorski J, Williams CB, Wang D, Wen R) J Exp Med 2010 Feb 15;207(2):309-18 100 Citations |
| 1 | Lack of evidence for a pathogenic role of T-lymphocytes in an animal model for Charcot-Marie-Tooth disease 1A. (Kohl B, Groh J, Wessig C, Wiendl H, Kroner A, Martini R) Neurobiol Dis 2010 Apr;38(1):78-84 12 Citations |
| 1 | PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice. (Valenzuela JO, Iclozan C, Hossain MS, Prlic M, Hopewell E, Bronk CC, Wang J, Celis E, Engelman RW, Blazar BR, Bevan MJ, Waller EK, Yu XZ, Beg AA) J Clin Invest 2009 Dec;119(12):3774-86 64 Citations |
| 1 | Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies. (Hamadani M, Blum W, Phillips G, Elder P, Andritsos L, Hofmeister C, O'Donnell L, Klisovic R, Penza S, Garzon R, Krugh D, Lin T, Bechtel T, Benson DM, Byrd JC, Marcucci G, Devine SM) Biol Blood Marrow Transplant 2009 Nov;15(11):1422-30 74 Citations |
| 1 | Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: a regulator of bone marrow-derived dendritic cells. (Maekawa Y, Mizue N, Chan A, Shi Y, Liu Y, Dawood S, Chen M, Dawood F, de Couto G, Li GH, Suzuki N, Yeh WC, Gramolini A, Medin JA, Liu PP) Circulation 2009 Oct 06;120(14):1401-14 65 Citations |
| 2 | Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease. (Filicko-O'Hara J, Grosso D, Flomenberg PR, Friedman TM, Brunner J, Drobyski W, Ferber A, Kakhniashvili I, Keever-Taylor C, Mookerjee B, Talano JA, Wagner JI, Korngold R, Flomenberg N) Biol Blood Marrow Transplant 2009 Dec;15(12):1609-19 7 Citations |
| 2 | Apoptosis of CD4+ CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation. (Jailwala P, Waukau J, Glisic S, Jana S, Ehlenbach S, Hessner M, Alemzadeh R, Matsuyama S, Laud P, Wang X, Ghosh S) PLoS One 2009 Aug 05;4(8):e6527 71 Citations |
| 1 | T-cell co-regulatory molecule expression in renal angiomyolipoma and pulmonary lymphangioleiomyomatosis. (Boorjian SA, Sheinin Y, Crispen PL, Lohse CM, Leibovich BC, Kwon ED) Urology 2009 Dec;74(6):1359-64 9 Citations |
| 1 | Accelerated course of experimental autoimmune encephalomyelitis in PD-1-deficient central nervous system myelin mutants. (Kroner A, Schwab N, Ip CW, Ortler S, Göbel K, Nave KA, Mäurer M, Martini R, Wiendl H) Am J Pathol 2009 Jun;174(6):2290-9 34 Citations |
| 2 | Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity. (Wilhelm AJ, Zabalawi M, Grayson JM, Weant AE, Major AS, Owen J, Bharadwaj M, Walzem R, Chan L, Oka K, Thomas MJ, Sorci-Thomas MG) Arterioscler Thromb Vasc Biol 2009 Jun;29(6):843-9 101 Citations |
| 1 | Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases. (Chavin G, Sheinin Y, Crispen PL, Boorjian SA, Roth TJ, Rangel L, Blute ML, Sebo TJ, Tindall DJ, Kwon ED, Karnes RJ) Clin Cancer Res 2009 Mar 15;15(6):2174-80 70 Citations |
| 1 | Potent induction of B- and T-cell immunity against human carcinoembryonic antigen-expressing tumors in human carcinoembryonic antigen transgenic mice mediated by direct lentivector injection. (Loisel-Meyer S, Felizardo T, Mariotti J, Mossoba ME, Foley JE, Kammerer R, Mizue N, Keefe R, McCart JA, Zimmermann W, Dropulic B, Fowler DH, Medin JA) Mol Cancer Ther 2009 Mar;8(3):692-702 18 Citations |
| 1 | Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cells. (Symes JC, Siatskas C, Fowler DH, Medin JA) Cancer Gene Ther 2009 May;16(5):439-52 7 Citations |
| 1 | Cholangiocytes as immune modulators in rotavirus-induced murine biliary atresia. (Barnes BH, Tucker RM, Wehrmann F, Mack DG, Ueno Y, Mack CL) Liver Int 2009 Sep;29(8):1253-61 52 Citations |
| 5 | Impaired survival of peripheral T cells, disrupted NK/NKT cell development, and liver failure in mice lacking Gimap5. (Schulteis RD, Chu H, Dai X, Chen Y, Edwards B, Haribhai D, Williams CB, Malarkannan S, Hessner MJ, Glisic-Milosavljevic S, Jana S, Kerschen EJ, Ghosh S, Wang D, Kwitek AE, Lernmark A, Gorski J, Weiler H) Blood 2008 Dec 15;112(13):4905-14 49 Citations |
| 3 | Rap1b regulates B cell development, homing, and T cell-dependent humoral immunity. (Chu H, Awasthi A, White GC 2nd, Chrzanowska-Wodnicka M, Malarkannan S) J Immunol 2008 Sep 01;181(5):3373-83 51 Citations |
| 1 | T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival. (Boorjian SA, Sheinin Y, Crispen PL, Farmer SA, Lohse CM, Kuntz SM, Leibovich BC, Kwon ED, Frank I) Clin Cancer Res 2008 Aug 01;14(15):4800-8 229 Citations |
| 1 | Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo. (Zhou Q, Yan X, Gershan J, Orentas RJ, Johnson BD) J Immunol 2008 Aug 01;181(3):1877-86 34 Citations |
| 1 | RSV infection--an immune balancing act: commentary on the article by Bem et al. on page 650. (Verbsky JW, Grossman WJ) Pediatr Res 2008 Jun;63(6):599-601 |
| 1 | Immuno-gene therapy approaches for cancer: from in vitro studies to clinical trials. (Loisel-Meyer S, Foley R, Medin JA) Front Biosci 2008 May 01;13:3202-14 20 Citations |
| 1 | B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis. (Ortler S, Leder C, Mittelbronn M, Zozulya AL, Knolle PA, Chen L, Kroner A, Wiendl H) Eur J Immunol 2008 Jun;38(6):1734-44 62 Citations |
| 1 | Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. (Basso AS, Frenkel D, Quintana FJ, Costa-Pinto FA, Petrovic-Stojkovic S, Puckett L, Monsonego A, Bar-Shir A, Engel Y, Gozin M, Weiner HL) J Clin Invest 2008 Apr;118(4):1532-43 187 Citations |
| 1 | L-Xylulose reductase is involved in 9,10-phenanthrenequinone-induced apoptosis in human T lymphoma cells. (Matsunaga T, Kamiya T, Sumi D, Kumagai Y, Kalyanaraman B, Hara A) Free Radic Biol Med 2008 Mar 15;44(6):1191-202 53 Citations |
| 1 | Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. (Trivedi P, Hematti P) Exp Hematol 2008 Mar;36(3):350-9 152 Citations |
| 1 | Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects. (Liang Y, Liu C, Djeu JY, Zhong B, Peters T, Scharffetter-Kochanek K, Anasetti C, Yu XZ) Blood 2008 Jan 15;111(2):954-62 44 Citations |
| 1 | Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis. (Opavsky R, Tsai SY, Guimond M, Arora A, Opavska J, Becknell B, Kaufmann M, Walton NA, Stephens JA, Fernandez SA, Muthusamy N, Felsher DW, Porcu P, Caligiuri MA, Leone G) Proc Natl Acad Sci U S A 2007 Sep 25;104(39):15400-5 50 Citations |
| 1 | Targeting TNFalpha rapidly reduces density of dendritic cells and macrophages in psoriatic plaques with restoration of epidermal keratinocyte differentiation. (Marble DJ, Gordon KB, Nickoloff BJ) J Dermatol Sci 2007 Nov;48(2):87-101 54 Citations |
| 1 | The impact of chimerism patterns and predonor leukocyte infusion lymphopenia on survival following T cell-depleted reduced intensity conditioned transplants. (Shaw BE, Byrne JL, Das-Gupta E, Carter GI, Russell NH) Biol Blood Marrow Transplant 2007 May;13(5):550-9 24 Citations |
| 1 | Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. (Maresz K, Pryce G, Ponomarev ED, Marsicano G, Croxford JL, Shriver LP, Ledent C, Cheng X, Carrier EJ, Mann MK, Giovannoni G, Pertwee RG, Yamamura T, Buckley NE, Hillard CJ, Lutz B, Baker D, Dittel BN) Nat Med 2007 Apr;13(4):492-7 310 Citations |
| 1 | Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapy. (Sato T, Neschadim A, Konrad M, Fowler DH, Lavie A, Medin JA) Mol Ther 2007 May;15(5):962-70 86 Citations |
| 1 | Alefacept in corticosteroid refractory graft versus host disease: early results indicate promising activity. (Toor AA, Stiff PJ, Nickoloff BJ, Rodriguez T, Klein JL, Gordon KB) J Dermatolog Treat 2007;18(1):13-8 19 Citations |
| 3 | Homeostatic expansion and repertoire regeneration of donor T cells during graft versus host disease is constrained by the host environment. (Gorski J, Chen X, Gendelman M, Yassai M, Krueger A, Tivol E, Logan B, Komorowski R, Vodanovic-Jankovic S, Drobyski WR) Blood 2007 Jun 15;109(12):5502-10 16 Citations |
| 1 | Induction of immunity to neuroblastoma early after syngeneic hematopoietic stem cell transplantation using a novel mouse tumor vaccine. (Jing W, Orentas RJ, Johnson BD) Biol Blood Marrow Transplant 2007 Mar;13(3):277-92 19 Citations |
| 1 | [Mechanisms involved in the regulation of immune response in experimental autoimmune encephalomyelitis in mice]. (Tutaj M, Szczepanik M) Postepy Hig Med Dosw (Online) 2006;60:571-83 3 Citations |
| 1 | Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia. (Mack CL, Tucker RM, Lu BR, Sokol RJ, Fontenot AP, Ueno Y, Gill RG) Hepatology 2006 Nov;44(5):1231-9 114 Citations |
| 2 | Recent molecular and cellular advances in pediatric bone marrow transplantation. (Talano JA, Margolis DA) Pediatr Clin North Am 2006 Aug;53(4):685-98 2 Citations |
| 1 | Calcium influx: beyond 'current' biology. (Robinson LC, Marchant JS) Curr Biol 2006 Jul 25;16(14):R548-50 2 Citations |
| 1 | The role of leukemia-derived B7-H1 (PD-L1) in tumor-T-cell interactions in humans. (Salih HR, Wintterle S, Krusch M, Kroner A, Huang YH, Chen L, Wiendl H) Exp Hematol 2006 Jul;34(7):888-94 45 Citations |
| 1 | T-cell tolerance or function is determined by combinatorial costimulatory signals. (Nurieva R, Thomas S, Nguyen T, Martin-Orozco N, Wang Y, Kaja MK, Yu XZ, Dong C) EMBO J 2006 Jun 07;25(11):2623-33 197 Citations |
| 1 | Flow cytometric features of angioimmunoblastic T-cell lymphoma. (Chen W, Kesler MV, Karandikar NJ, McKenna RW, Kroft SH) Cytometry B Clin Cytom 2006 May;70(3):142-8 46 Citations |
| 1 | Tumor-derived macrophage migration inhibitory factor (MIF) inhibits T lymphocyte activation. (Yan X, Orentas RJ, Johnson BD) Cytokine 2006 Feb 21;33(4):188-98 38 Citations |
| 1 | The virtual crossmatch--a screening tool for sensitized pediatric heart transplant recipients. (Zangwill SD, Ellis TM, Zlotocha J, Jaquiss RD, Tweddell JS, Mussatto KA, Berger S) Pediatr Transplant 2006 Feb;10(1):38-41 72 Citations |
| 1 | Of mice and men: use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humans. (Serreze DV, Chen YG) Trends Immunol 2005 Nov;26(11):603-7 20 Citations |
| 1 | Neuroblastoma cells transiently transfected to simultaneously express the co-stimulatory molecules CD54, CD80, CD86, and CD137L generate antitumor immunity in mice. (Johnson BD, Gershan JA, Natalia N, Zujewski H, Weber JJ, Yan X, Orentas RJ) J Immunother 2005;28(5):449-60 32 Citations |
| 1 | Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclerosis. (Vogler S, Goedde R, Miterski B, Gold R, Kroner A, Koczan D, Zettl UK, Rieckmann P, Epplen JT, Ibrahim SM) J Mol Med (Berl) 2005 Oct;83(10):806-11 60 Citations |
| 1 | Diversity of NKR expression in aging T cells and in T cells of the aged: the new frontier into the exploration of protective immunity in the elderly. (Abedin S, Michel JJ, Lemster B, Vallejo AN) Exp Gerontol 2005 Jul;40(7):537-48 56 Citations |
| 1 | Autoantibodies to vascular smooth muscle are pathogenic for vasculitis. (Baiu DC, Barger B, Sandor M, Fabry Z, Hart MN) Am J Pathol 2005 Jun;166(6):1851-60 11 Citations |
| 1 | Epicutaneously induced TGF-beta-dependent tolerance inhibits experimental autoimmune encephalomyelitis. (Szczepanik M, Tutaj M, Bryniarski K, Dittel BN) J Neuroimmunol 2005 Jul;164(1-2):105-14 46 Citations |
| 1 | Unraveling the pathogenesis and etiology of biliary atresia. (Mack CL, Sokol RJ) Pediatr Res 2005 May;57(5 Pt 2):87R-94R 121 Citations |
| 1 | Emergent autoimmunity in graft-versus-host disease. (Tivol E, Komorowski R, Drobyski WR) Blood 2005 Jun 15;105(12):4885-91 105 Citations |
| 1 | Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. (Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K, O'Reilly RJ, Horowitz MM, Dupont B) Blood 2005 Jun 15;105(12):4878-84 415 Citations |
| 1 | Functional reprogramming of the primary immune response by T cell receptor antagonism. (Haribhai D, Edwards B, Williams ML, Williams CB) J Exp Med 2004 Dec 06;200(11):1371-82 10 Citations |
| 1 | Unanticipated antigens: translation initiation at CUG with leucine. (Schwab SR, Shugart JA, Horng T, Malarkannan S, Shastri N) PLoS Biol 2004 Nov;2(11):e366 87 Citations |
| 1 | Human T regulatory cells can use the perforin pathway to cause autologous target cell death. (Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ) Immunity 2004 Oct;21(4):589-601 779 Citations |
| 1 | Expression of CD200 on epithelial cells of the murine hair follicle: a role in tissue-specific immune tolerance? (Rosenblum MD, Olasz EB, Yancey KB, Woodliff JE, Lazarova Z, Gerber KA, Truitt RL) J Invest Dermatol 2004 Nov;123(5):880-7 92 Citations |
| 1 | Prevention of lethal acute GVHD with an agonistic CD28 antibody and rapamycin. (Albert MH, Yu XZ, Martin PJ, Anasetti C) Blood 2005 Feb 01;105(3):1355-61 20 Citations |
| 1 | From laboratory to clinic: rationale for biologic therapy. (Mehlis S, Gordon KB) Dermatol Clin 2004 Oct;22(4):371-7, vii-viii 15 Citations |
| 1 | Transgenic rescue demonstrates involvement of the Ian5 gene in T cell development in the rat. (Michalkiewicz M, Michalkiewicz T, Ettinger RA, Rutledge EA, Fuller JM, Moralejo DH, Van Yserloo B, MacMurray AJ, Kwitek AE, Jacob HJ, Lander ES, Lernmark A) Physiol Genomics 2004 Oct 04;19(2):228-32 32 Citations |
| 1 | Phosphatidylserine regulates the maturation of human dendritic cells. (Chen X, Doffek K, Sugg SL, Shilyansky J) J Immunol 2004 Sep 01;173(5):2985-94 90 Citations |
| 1 | Unusual immunophenotype of CD8+ T cells in familial hemophagocytic lymphohistiocytosis. (Karandikar NJ, Kroft SH, Yegappan S, Rogers BB, Aquino VM, Lee KM, Kumar V, Guenaga FJ, Jaffe ES, Douek DC, McKenna RW) Blood 2004 Oct 01;104(7):2007-9 18 Citations |
| 1 | CD28 ligation induces transplantation tolerance by IFN-gamma-dependent depletion of T cells that recognize alloantigens. (Yu XZ, Albert MH, Martin PJ, Anasetti C) J Clin Invest 2004 Jun;113(11):1624-30 56 Citations |
| 1 | Successful treatment of systemic and central nervous system lymphomatoid granulomatosis with rituximab. (Zaidi A, Kampalath B, Peltier WL, Vesole DH) Leuk Lymphoma 2004 Apr;45(4):777-80 53 Citations |
| 1 | The T cell activation marker CD150 can be used to identify alloantigen-activated CD4(+)25+ regulatory T cells. (Browning MB, Woodliff JE, Konkol MC, Pati NT, Ghosh S, Truitt RL, Johnson BD) Cell Immunol 2004 Feb;227(2):129-39 17 Citations |
| 1 | WIP regulates signaling via the high affinity receptor for immunoglobulin E in mast cells. (Kettner A, Kumar L, Antón IM, Sasahara Y, de la Fuente M, Pivniouk VI, Falet H, Hartwig JH, Geha RS) J Exp Med 2004 Feb 02;199(3):357-68 42 Citations |
| 1 | Difference in gene expression profiles between human CD4+CD25+ and CD4+CD25- T cells. (Pati N, Ghosh S, Hessner MJ, Khoo HJ, Wang X) Ann N Y Acad Sci 2003 Nov;1005:279-83 6 Citations |
| 1 | Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial. (Gordon KB, Papp KA, Hamilton TK, Walicke PA, Dummer W, Li N, Bresnahan BW, Menter A, Efalizumab Study Group) JAMA 2003 Dec 17;290(23):3073-80 383 Citations |
| 1 | Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution. (Gendelman M, Yassai M, Tivol E, Krueger A, Gorski J, Drobyski WR) Biol Blood Marrow Transplant 2003 Dec;9(12):742-52 11 Citations |
| 1 | Evolution of biologic therapies for the treatment of psoriasis. (Gordon KB, McCormick TS) Skinmed 2003;2(5):286-94 9 Citations |
| 1 | Genetic dissection of lymphopenia from autoimmunity by introgression of mutated Ian5 gene onto the F344 rat. (Moralejo DH, Park HA, Speros SJ, MacMurray AJ, Kwitek AE, Jacob HJ, Lander ES, Lernmark A) J Autoimmun 2003 Dec;21(4):315-24 32 Citations |
| 1 | Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells. (Cho CS, Chang Z, Elkahwaji J, Scheunemann TL, Manthei ER, Colburn M, Knechtle SJ, Hamawy MM) Int Immunol 2003 Nov;15(11):1369-78 11 Citations |
| 1 | The mutational spectrum of the HPRT gene from human T cells in vivo shares a significant concordant set of hot spots with MNNG-treated human cells. (Tomita-Mitchell A, Ling LL, Glover CL, Goodluck-Griffith J, Thilly WG) Cancer Res 2003 Sep 15;63(18):5793-8 9 Citations |
| 1 | The immunology of psoriasis and biologic immunotherapy. (Mehlis SL, Gordon KB) J Am Acad Dermatol 2003 Aug;49(2 Suppl):S44-50 108 Citations |
| 1 | Neuroblastoma cells inhibit the immunostimulatory function of dendritic cells. (Chen X, Doffek K, Sugg SL, Shilyansky J) J Pediatr Surg 2003 Jun;38(6):901-5 9 Citations |
| 1 | The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation. (Shaw BE, Potter MN, Mayor NP, Pay AL, Smith C, Goldman JM, Prentice HG, Marsh SG, Madrigal JA) Bone Marrow Transplant 2003 Jun;31(11):1001-8 51 Citations |
| 1 | Regulation of alloresponses after bone marrow transplantation using donor T cells expressing a thymidine kinase suicide gene. (Drobyski WR, Gendelman M) Leuk Lymphoma 2002 Oct;43(10):2011-6 9 Citations |
| 1 | Functional recovery after facial nerve crush is delayed in severe combined immunodeficient mice. (Serpe CJ, Tetzlaff JE, Coers S, Sanders VM, Jones KJ) Brain Behav Immun 2002 Dec;16(6):808-12 40 Citations |
| 1 | B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. (Tsuji RF, Szczepanik M, Kawikova I, Paliwal V, Campos RA, Itakura A, Akahira-Azuma M, Baumgarth N, Herzenberg LA, Askenase PW) J Exp Med 2002 Nov 18;196(10):1277-90 117 Citations |
| 1 | Modulation of the electrophoretic mobility of the linker for activation of T cells (LAT) by the calcineurin inhibitors CsA and FK506: LAT is a potential substrate for PKC and calcineurin signaling pathways. (Cho CS, Elkahwaji J, Chang Z, Scheunemann TL, Manthei ER, Hamawy MM) Cell Signal 2003 Jan;15(1):85-93 12 Citations |
| 1 | Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes. (Syme RM, Spurrell JC, Amankwah EK, Green FH, Mody CH) Infect Immun 2002 Nov;70(11):5972-81 116 Citations |
| 1 | Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. (Howard OM, Dong HF, Yang D, Raben N, Nagaraju K, Rosen A, Casciola-Rosen L, Härtlein M, Kron M, Yang D, Yiadom K, Dwivedi S, Plotz PH, Oppenheim JJ) J Exp Med 2002 Sep 16;196(6):781-91 237 Citations |
| 1 | Role of the passive apoptotic pathway in graft-versus-host disease. (Drobyski WR, Komorowski R, Logan B, Gendelman M) J Immunol 2002 Aug 01;169(3):1626-33 13 Citations |
| 1 | Chronic myelogenous leukemia in T cell lymphoid blastic phase achieving durable complete cytogenetic and molecular remission with imatinib mesylate (STI571; Gleevec) therapy. (Atallah E, Talpaz M, O'brien S, Rios MB, Guo JQ, Arlinghaus R, Fernandes-Reese S, Kantarjian H) Cancer 2002 Jun 01;94(11):2996-9 18 Citations |
| 1 | Epicutaneous application of protein antigens incorporated into cosmetic cream induces antigen-nonspecific unresponsiveness in mice and affects the cell-mediated immune response. (Ptak W, Szczepanik M, Bryniarski K, Tutaj M, Ptak M) Int Arch Allergy Immunol 2002 May;128(1):8-14 31 Citations |
| 1 | Biologic therapy for psoriasis: the new therapeutic frontier. (Singri P, West DP, Gordon KB) Arch Dermatol 2002 May;138(5):657-63 107 Citations |
| 1 | Differential abilities of central nervous system resident endothelial cells and astrocytes to serve as inducible antigen-presenting cells. (Girvin AM, Gordon KB, Welsh CJ, Clipstone NA, Miller SD) Blood 2002 May 15;99(10):3692-701 46 Citations |
| 1 | Comparison of monocyte enrichment by immuno-magnetic depletion or adherence for the clinical-scale generation of DC. (Suen Y, Lee SM, Aono F, Hou S, Loudovaris M, Ofstein G, Bender JG) Cytotherapy 2001;3(5):365-75 38 Citations |
| 1 | Zinc-mediated dimerization and its effect on activity and conformation of staphylococcal enterotoxin type C. (Chi YI, Sadler I, Jablonski LM, Callantine SD, Deobald CF, Stauffacher CV, Bohach GA) J Biol Chem 2002 Jun 21;277(25):22839-46 29 Citations |
| 1 | Differential requirement for SLP-76 domains in T cell development and function. (Myung PS, Derimanov GS, Jordan MS, Punt JA, Liu QH, Judd BA, Meyers EE, Sigmund CD, Freedman BD, Koretzky GA) Immunity 2001 Dec;15(6):1011-26 88 Citations |
| 4 | Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. (Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR) Biol Blood Marrow Transplant 2001;7(11):620-30 56 Citations |
| 1 | Electrofusion of a weakly immunogenic neuroblastoma with dendritic cells produces a tumor vaccine. (Orentas RJ, Schauer D, Bin Q, Johnson BD) Cell Immunol 2001 Oct 10;213(1):4-13 56 Citations |
| 1 | The cell biology of antigen presentation. (Hudson AW, Ploegh HL) Exp Cell Res 2002 Jan 01;272(1):1-7 31 Citations |
| 1 | Requirement for Ca2+/calmodulin-dependent kinase type IV/Gr in setting the thymocyte selection threshold. (Raman V, Blaeser F, Ho N, Engle DL, Williams CB, Chatila TA) J Immunol 2001 Dec 01;167(11):6270-8 24 Citations |
| 1 | Lipopolysaccharide-stimulated or granulocyte-macrophage colony-stimulating factor-stimulated monocytes rapidly express biologically active IL-15 on their cell surface independent of new protein synthesis. (Neely GG, Robbins SM, Amankwah EK, Epelman S, Wong H, Spurrell JC, Jandu KK, Zhu W, Fogg DK, Brown CB, Mody CH) J Immunol 2001 Nov 01;167(9):5011-7 65 Citations |
| 1 | Immunophenotypic analysis of peripheral T-cell neoplasms. A multiparameter flow cytometric approach. (Jamal S, Picker LJ, Aquino DB, McKenna RW, Dawson DB, Kroft SH) Am J Clin Pathol 2001 Oct;116(4):512-26 116 Citations |
| 1 | Phenotypic analysis of conditionally immortalized cells isolated from the BPK model of ARPKD. (Sweeney WE Jr, Kusner L, Carlin CR, Chang S, Futey L, Cotton CU, Dell KM, Avner ED) Am J Physiol Cell Physiol 2001 Nov;281(5):C1695-705 22 Citations |
| 1 | Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34(+) cell dose. (Keever-Taylor CA, Klein JP, Eastwood D, Bredeson C, Margolis DA, Burns WH, Vesole DH) Bone Marrow Transplant 2001 Apr;27(8):791-800 22 Citations |
| 1 | In vitro T-cell receptor V beta repertoire analysis may identify which T-cell V beta families mediate graft-versus-leukaemia and graft-versus-host responses after human leucocyte antigen-matched sibling stem cell transplantation. (Epperson DE, Margolis DA, McOlash L, Janczak T, Barrett AJ) Br J Haematol 2001 Jul;114(1):57-62 18 Citations |
| 1 | T cell proliferation and cytokine secretion to T cell epitopes of Asp f 2 in ABPA patients. (Rathore VB, Johnson B, Fink JN, Kelly KJ, Greenberger PA, Kurup VP) Clin Immunol 2001 Aug;100(2):228-35 26 Citations |
| 1 | Production of MDC/CCL22 by human intestinal epithelial cells. (Berin MC, Dwinell MB, Eckmann L, Kagnoff MF) Am J Physiol Gastrointest Liver Physiol 2001 Jun;280(6):G1217-26 61 Citations |
| 1 | Prognostic significance of tumour-infiltrating T lymphocytes and T-cell subsets in de novo diffuse large B-cell lymphoma: a multiparameter flow cytometry study. (Xu Y, Kroft SH, McKenna RW, Aquino DB) Br J Haematol 2001 Mar;112(4):945-9 40 Citations |
| 1 | Mycobacterium bovis BCG-induced granuloma formation depends on gamma interferon and CD40 ligand but does not require CD28. (Hogan LH, Markofski W, Bock A, Barger B, Morrissey JD, Sandor M) Infect Immun 2001 Apr;69(4):2596-603 40 Citations |
| 1 | Unregulated inflammation shortens human functional longevity. (Brod SA) Inflamm Res 2000 Nov;49(11):561-70 77 Citations |
| 1 | Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis. (Chen X, Woiciechowsky A, Raffegerst S, Schendel D, Kolb HJ, Roskrow M) Br J Haematol 2000 Dec;111(3):817-25 54 Citations |
| 1 | A migratory population of skin-derived dendritic cells expresses CXCR5, responds to B lymphocyte chemoattractant in vitro, and co-localizes to B cell zones in lymph nodes in vivo. (Saeki H, Wu MT, Olasz E, Hwang ST) Eur J Immunol 2000 Oct;30(10):2808-14 62 Citations |
| 1 | Generation of antigen-specific, lacZ-inducible T-cell hybrids. (Malarkannan S, Mendoza LM, Shastri N) Methods Mol Biol 2001;156:265-72 18 Citations |
| 2 | Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation. (Carstens C, Newman DK, Bohlen H, König A, Koch N) Int Immunol 2000 Nov;12(11):1561-8 9 Citations |
| 2 | Infiltrating T cells during liver graft-versus-host disease show a restricted T-cell repertoire. (Margolis DA, Casper JT, Segura AD, Janczak T, McOlash L, Fisher B, Miller K, Gorski J) Biol Blood Marrow Transplant 2000;6(4):408-15 21 Citations |
| 1 | Identification of in vivo mutations in exon 5 of the human HPRT gene in a set of pooled T-cell mutants by constant denaturant capillary electrophoresis (CDCE). (Fält S, Kumar R, Wennborg A, Tomita-Mitchell A, Thilly WG, Lambert B) Mutat Res 2000 Jul 20;452(1):57-66 |
| 1 | Evolving strategies to address adverse transplant outcomes associated with T cell depletion. (Drobyski WR) J Hematother Stem Cell Res 2000 Jun;9(3):327-37 24 Citations |
| 3 | T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. (Champlin RE, Passweg JR, Zhang MJ, Rowlings PA, Pelz CJ, Atkinson KA, Barrett AJ, Cahn JY, Drobyski WR, Gale RP, Goldman JM, Gratwohl A, Gordon-Smith EC, Henslee-Downey PJ, Herzig RH, Klein JP, Marmont AM, O'Reilly RJ, Ringdén O, Slavin S, Sobocinski KA, Speck B, Weiner RS, Horowitz MM) Blood 2000 Jun 15;95(12):3996-4003 138 Citations |
| 1 | CD28-specific antibody prevents graft-versus-host disease in mice. (Yu XZ, Bidwell SJ, Martin PJ, Anasetti C) J Immunol 2000 May 01;164(9):4564-8 80 Citations |
| 1 | Prominent expression of mRNA for proinflammatory cytokines in synovium in patients with juvenile rheumatoid arthritis or chronic Lyme arthritis. (Harjacek M, Diaz-Cano S, Alman BA, Coburn J, Ruthazer R, Wolfe H, Steere AC) J Rheumatol 2000 Feb;27(2):497-503 43 Citations |
| 1 | Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation. (Truitt RL, Johnson BD, Hanke C, Talib S, Hearst JE) J Immunol 1999 Nov 01;163(9):5145-56 47 Citations |
| 1 | Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. (Curtis RE, Travis LB, Rowlings PA, Socié G, Kingma DW, Banks PM, Jaffe ES, Sale GE, Horowitz MM, Witherspoon RP, Shriner DA, Weisdorf DJ, Kolb HJ, Sullivan KM, Sobocinski KA, Gale RP, Hoover RN, Fraumeni JF Jr, Deeg HJ) Blood 1999 Oct 01;94(7):2208-16 578 Citations |
| 3 | T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation. (Drobyski WR, Hessner MJ, Klein JP, Kabler-Babbitt C, Vesole DH, Margolis DA, Keever-Taylor CA) Blood 1999 Jul 15;94(2):434-41 77 Citations |
| 1 | A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction. (Newton-Nash DK, Newman PJ) J Immunol 1999 Jul 15;163(2):682-8 142 Citations |
| 1 | A kinetic threshold between negative and positive selection based on the longevity of the T cell receptor-ligand complex. (Williams CB, Engle DL, Kersh GJ, Michael White J, Allen PM) J Exp Med 1999 May 17;189(10):1531-44 98 Citations |
| 1 | A new paradigm of T cell allergy: requirement for the B-1 cell subset. (Askenase PW, Kawikova I, Paliwal V, Akahira-Azuma M, Gerard C, Hugli T, Tsuji R) Int Arch Allergy Immunol 1999;118(2-4):145-9 21 Citations |
| 1 | Immunodominant peptide epitopes of allergen, Asp f 1 from the fungus Aspergillus fumigatus. (Kurup VP, Banerjee B, Murali PS, Greenberger PA, Krishnan M, Hari V, Fink JN) Peptides 1998;19(9):1469-77 40 Citations |
| 1 | In vivo antagonism of a T cell response by an endogenously expressed ligand. (Basu D, Williams CB, Allen PM) Proc Natl Acad Sci U S A 1998 Nov 24;95(24):14332-6 35 Citations |
| 1 | The molecular and functional characterization of a dominant minor H antigen, H60. (Malarkannan S, Shih PP, Eden PA, Horng T, Zuberi AR, Christianson G, Roopenian D, Shastri N) J Immunol 1998 Oct 01;161(7):3501-9 212 Citations |
| 3 | T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up. (Juckett M, Rowlings P, Hessner M, Keever-Taylor C, Burns W, Camitta B, Casper J, Drobyski WR, Hanson G, Horowitz M, Lawton C, Margolis J, Peitryga D, Vesole D) Bone Marrow Transplant 1998 May;21(9):893-9 48 Citations |
| 1 | Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes. (Tan L, Gordon KB, Mueller JP, Matis LA, Miller SD) J Immunol 1998 May 01;160(9):4271-9 107 Citations |
| 1 | T-cell-rich B-cell lymphoma and Epstein-Barr virus infection of the uterus in a postmenopausal patient with an intrauterine contraceptive device in place for over 20 years. (Gutman PD, Williams JP, Dveksler GS, Hoffmeister K, Cotelingam JD) Gynecol Oncol 1998 Mar;68(3):288-92 19 Citations |
| 1 | Glycosphingolipids as novel targets for T-cell suppression by the B subunit of recombinant heat-labile enterotoxin. (Truitt RL, Hanke C, Radke J, Mueller R, Barbieri JT) Infect Immun 1998 Apr;66(4):1299-308 35 Citations |
| 1 | Aggregated immunoglobulin protects immune T cells from suppression: dependence on isotype, Fc portion, and macrophage FcgammaR. (Ptak W, Paliwal V, Bryniarski K, Ptak M, Askenase PW) Scand J Immunol 1998 Feb;47(2):136-45 13 Citations |
| 1 | Recombinant soluble alphabeta T cell receptors protect T cells from immune suppression: requirement for aggregated multimeric, disulfide-linked alphabeta heterodimers. (Paliwal V, Ptak W, Sperl J, Braswell E, Askenase PW) J Immunol 1997 Aug 15;159(4):1718-27 3 Citations |
| 1 | Concurrent or sequential delta and beta TCR gene rearrangement during thymocyte development: individual thymi follow distinct pathways. (Margolis D, Yassai M, Hletko A, McOlash L, Gorski J) J Immunol 1997 Jul 15;159(2):529-33 11 Citations |
| 1 | IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. (Nikcevich KM, Gordon KB, Tan L, Hurst SD, Kroepfl JF, Gardinier M, Barrett TA, Miller SD) J Immunol 1997 Jan 15;158(2):614-21 139 Citations |
| 1 | Interferon-gamma secretion defects in haemophilia A patients receiving highly purified plasma-derived or recombinant factor VIII. (Newton-Nash DK, Tollerud D, Guevarra L, Gill JC) Br J Haematol 1996 Dec;95(3):554-60 6 Citations |
| 1 | Induction of apoptosis by anti-CD3 epsilon F(ab')2 in antigen receptor transgenic murine T cells activated by specific peptide. (Yu XZ, Zhu L, Davis JE, Tso JY, Hansen JA, Anasetti C) J Immunol 1996 Oct 15;157(8):3420-9 19 Citations |
| 1 | Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation. (Drobyski WR, Potluri J, Sauer D, Gottschall JL) Bone Marrow Transplant 1996 Jun;17(6):1093-9 93 Citations |
| 1 | T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex. Effects of conservative amino acid substitutions at anchor position 1 of influenza matrix protein19-31. (Wu S, Gorski J, Eckels DD, Newton-Nash DK) J Immunol 1996 May 15;156(10):3815-20 22 Citations |
| 1 | Endogenous altered peptide ligands can affect peripheral T cell responses. (Vidal K, Hsu BL, Williams CB, Allen PM) J Exp Med 1996 Apr 01;183(4):1311-21 60 Citations |
| 1 | Silicone-induced T cell proliferation in mice. (McDonald AH, Weir K, Sanger JR) Curr Top Microbiol Immunol 1996;210:189-98 8 Citations |
| 1 | Leukocyte trafficking in free-flowing cerebrospinal fluid of normal rhesus macaques (Macaca mulatta). (Hou FY, Coe CL, Erickson C) J Med Primatol 1996 Jan;25(1):8-13 4 Citations |
| 1 | Cell cycle control of T cell apoptosis induced by activation through the T cell antigen receptor. (Chalupny NJ, Zhu L, Yu XZ, Anasetti C) Adv Exp Med Biol 1996;406:57-67 |
| 1 | Interleukin-6: biologic properties and role in lymphoproliferative disorders. (Seymour JF, Kurzrock R) Cancer Treat Res 1996;84:167-206 9 Citations |
| 1 | A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells. (Malarkannan S, Afkarian M, Shastri N) J Exp Med 1995 Dec 01;182(6):1739-50 63 Citations |
| 3 | Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia. (Hessner MJ, Endean DJ, Casper JT, Horowitz MM, Keever-Taylor CA, Roth M, Flomenberg N, Drobyski WR) Blood 1995 Nov 15;86(10):3987-96 59 Citations |
| 1 | Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease. (Johnson BD, Truitt RL) Blood 1995 Jun 01;85(11):3302-12 134 Citations |
| 1 | Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis. (Brod SA, Khan M, Kerman RH, Pappolla M) J Neuroimmunol 1995 Apr;58(1):61-9 42 Citations |
| 1 | Investigation of the role of the disulphide bond in the activity and structure of staphylococcal enterotoxin C1. (Hovde CJ, Marr JC, Hoffmann ML, Hackett SP, Chi YI, Crum KK, Stevens DL, Stauffacher CV, Bohach GA) Mol Microbiol 1994 Sep;13(5):897-909 81 Citations |
| 2 | Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. (Drobyski WR, Ash RC, Casper JT, McAuliffe T, Horowitz MM, Lawton C, Keever C, Baxter-Lowe LA, Camitta B, Garbrecht F) Blood 1994 Apr 01;83(7):1980-7 122 Citations |
| 1 | Start site selection at the TATA-less carbamoyl-phosphate synthase (glutamine-hydrolyzing)/aspartate carbamoyltransferase/dihydroorotase promoter. (Kollmar R, Sukow KA, Sponagle SK, Farnham PJ) J Biol Chem 1994 Jan 21;269(3):2252-7 68 Citations |
| 1 | Defective CD3 mediated proliferation and LPS responsiveness in multiple sclerosis. (Brod SA, Scott M) Autoimmunity 1994;17(2):143-8 4 Citations |
| 1 | Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. (Graham MB, Dalton DK, Giltinan D, Braciale VL, Stewart TA, Braciale TJ) J Exp Med 1993 Nov 01;178(5):1725-32 221 Citations |
| 2 | Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. (Drobyski WR, Keever CA, Roth MS, Koethe S, Hanson G, McFadden P, Gottschall JL, Ash RC, van Tuinen P, Horowitz MM) Blood 1993 Oct 15;82(8):2310-8 331 Citations |
| 2 | Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. (Johnson BD, Drobyski WR, Truitt RL) Bone Marrow Transplant 1993 Apr;11(4):329-36 130 Citations |
| 1 | Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides. (Newton-Nash DK, Eckels DD) J Immunol 1993 Mar 01;150(5):1813-21 63 Citations |
| 1 | Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. (Beckerman KP, Rogers HW, Corbett JA, Schreiber RD, McDaniel ML, Unanue ER) J Immunol 1993 Feb 01;150(3):888-95 243 Citations |
| 1 | Reciprocal regulation of K+ channels by Ca2+ in intact human T lymphocytes. (Schlichter LC, Pahapill PA, Schumacher PA) Recept Channels 1993;1(3):201-15 18 Citations |
| 1 | Anti-pan T lymphocyte ricin A chain immunotoxin (H65-RTA) and methylprednisolone for acute GVHD prophylaxis following allogeneic BMT from HLA-identical sibling donors. (Krance R, Heslop HE, Mahmoud H, Ribeiro R, Douglass E, Hurwitz C, Santana V, Kun L, Horowitz MM, Brenner MK) Bone Marrow Transplant 1993 Jan;11(1):33-6 9 Citations |
| 1 | CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production. (Freeman GJ, Lombard DB, Gimmi CD, Brod SA, Lee K, Laning JC, Hafler DA, Dorf ME, Gray GS, Reiser H) J Immunol 1992 Dec 15;149(12):3795-801 155 Citations |
| 1 | Progress report from the International Bone Marrow Transplant Registry. (Bortin MM, Horowitz MM, Rimm AA) Bone Marrow Transplant 1992 Aug;10(2):113-22 21 Citations |
| 1 | What determines who develops graft-versus-host disease: the graft or the host (or both)? (Gale RP, Horowitz MM, Butturini A, Barrett AJ, Kolb HJ) Bone Marrow Transplant 1992 Aug;10(2):99-102 7 Citations |
| 1 | Dual action of 2,3-butanedione monoxime (BDM) on K+ current in human T lymphocytes. (Schlichter LC, Pahapill PA, Chung I) J Pharmacol Exp Ther 1992 May;261(2):438-46 39 Citations |
| 1 | Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors. (Estrov Z, Kurzrock R, Estey E, Wetzler M, Ferrajoli A, Harris D, Blake M, Gutterman JU, Talpaz M) Blood 1992 Apr 15;79(8):1938-45 78 Citations |
| 1 | Effects of localized HLA class II beta chain polymorphism on binding of antigenic peptide and stimulation of T cells. (Newton-Nash DK, Eckels DD) Hum Immunol 1992 Mar;33(3):213-23 15 Citations |
| 1 | Cl- channels in intact human T lymphocytes. (Pahapill PA, Schlichter LC) J Membr Biol 1992 Jan;125(2):171-83 56 Citations |
| 1 | Modulation of potassium channels in intact human T lymphocytes. (Pahapill PA, Schlichter LC) J Physiol 1992 Jan;445:407-30 47 Citations |
| 1 | T-cell depletion of HLA-identical transplants in leukemia. (Marmont AM, Horowitz MM, Gale RP, Sobocinski K, Ash RC, van Bekkum DW, Champlin RE, Dicke KA, Goldman JM, Good RA) Blood 1991 Oct 15;78(8):2120-30 720 Citations |
| 1 | Recognition of the influenza hemagglutinin by class II MHC-restricted T lymphocytes and antibodies. I. Site definition and implications for antigen presentation and T lymphocyte recognition. (Brown LR, Nygard NR, Graham MB, Bono C, Braciale VL, Gorka J, Schwartz BD, Braciale TJ) J Immunol 1991 Oct 15;147(8):2677-84 14 Citations |
| 1 | Regulation of lymphokine-activated killer activity in T-replete and T-cell-depleted human bone marrow by interleukin 4. (Drobyski WR, LeFever AV, Truitt RL) Exp Hematol 1991 Oct;19(9):950-7 1 Citation |
| 1 | Antibody recognition of an immunogenic influenza hemagglutinin-human leukocyte antigen class II complex. (Nygard NR, Bono C, Brown LR, Gorka J, Giacoletto KS, Schaiff WT, Graham MB, McCourt DW, Kabeer M, Braciale VL) J Exp Med 1991 Jul 01;174(1):243-51 15 Citations |
| 1 | The immunoregulatory effects of merocyanine 540 on in vitro human T- and B-lymphocyte functions. (Lum LG, Yamagami M, Giddings BR, Joshi I, Schober SL, Sensenbrenner LL, Sieber F) Blood 1991 Jun 15;77(12):2701-6 15 Citations |
| 1 | Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. (Ash RC, Horowitz MM, Gale RP, van Bekkum DW, Casper JT, Gordon-Smith EC, Henslee PJ, Kolb HJ, Lowenberg B, Masaoka T) Bone Marrow Transplant 1991 Jun;7(6):443-52 187 Citations |
| 1 | Common T-cell receptor V beta usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis. (Lee SJ, Wucherpfennig KW, Brod SA, Benjamin D, Weiner HL, Hafler DA) Ann Neurol 1991 Jan;29(1):33-40 58 Citations |
| 1 | Serotonin initiation of delayed-type hypersensitivity: mediation by a primitive Thy-1+ antigen-specific clone or by specific monoclonal IgE antibody. (Askenase PW, Herzog WR, Millet I, Paliwal V, Ramabhadran R, Rochester C, Geba GP, Ptak W) Skin Pharmacol 1991;4 Suppl 1:25-42 26 Citations |
| 1 | T-T cell interactions are mediated by adhesion molecules. (Brod SA, Purvee M, Benjamin D, Hafler DA) Eur J Immunol 1990 Oct;20(10):2259-68 43 Citations |
| 1 | Preservation of lymphokine-activated killer activity following T cell depletion of human bone marrow. (Drobyski WR, Piaskowski V, Ash RC, Casper JT, Truitt RL) Transplantation 1990 Oct;50(4):625-32 11 Citations |
| 1 | Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry. (Gale RP, Horowitz MM) Bone Marrow Transplant 1990 Jul;6 Suppl 1:94-7 27 Citations |
| 1 | A large, multiple-conductance chloride channel in normal human T lymphocytes. (Schlichter LC, Grygorczyk R, Pahapill PA, Grygorczyk C) Pflugers Arch 1990 Jun;416(4):413-21 56 Citations |
| 1 | Elimination of OX8+ cells prolongs cardiac but not pancreatic allograft survival across minor (non-MHC) histocompatibility barriers. (Roza AM, Johnson CP, Adams MB, Naji A) Transplant Proc 1990 Apr;22(2):747-8 1 Citation |
| 1 | Modulation of potassium channels in human T lymphocytes: effects of temperature. (Pahapill PA, Schlichter LC) J Physiol 1990 Mar;422:103-26 71 Citations |
| 1 | Graft-versus-leukemia reactions after bone marrow transplantation. (Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringdén O, Rozman C, Speck B) Blood 1990 Feb 01;75(3):555-62 2443 Citations |
| 1 | Frequency analysis of CD4+CD8+ T cells cloned with IL-4. (Brod SA, Purvee M, Benjamin D, Hafler DA) Cell Immunol 1990 Feb;125(2):426-36 24 Citations |
| 1 | Lymphokine regulation of CD45R expression on human T cell clones. (Brod SA, Rudd CE, Purvee M, Hafler DA) J Exp Med 1989 Dec 01;170(6):2147-52 58 Citations |
| 1 | Third-party-mediated graft rejection and graft-versus-host disease after T-cell-depleted bone marrow transplantation, as demonstrated by hypervariable DNA probes and HLA-DR polymorphism. (Drobyski W, Thibodeau S, Truitt RL, Baxter-Lowe LA, Gorski J, Jenkins R, Gottschall J, Ash RC) Blood 1989 Nov 01;74(6):2285-94 70 Citations |
| 1 | Effect of elimination of OX-19+ and OX-8+ T-cell subsets upon pancreatic allograft survival. (Roza AM, Markmann JF, Kimura H, Johnson CP, Adams MB, Naji A) J Surg Res 1989 Apr;46(4):395-9 1 Citation |
| 1 | Immunoregulation in multiple sclerosis. (Hafler DA, Brod SA, Weiner HL) Res Immunol 1989 Feb;140(2):233-9; discussion 245-8 5 Citations |
| 1 | Sleep deprivation in the rat: VII. Immune function. (Benca RM, Kushida CA, Everson CA, Kalski R, Bergmann BM, Rechtschaffen A) Sleep 1989 Feb;12(1):47-52 49 Citations |
| 1 | The classical and alternate pathways of T cell activation are impaired in leprosy. (Muthukkaruppan V, Chakkalath HR, Malarkannan S) Immunol Lett 1988 Sep;19(1):55-8 4 Citations |
| 1 | Cellular immunoregulation of acute pulmonary inflammation in strain 2 guinea pigs. (Pontzer CH, Newton-Nash DK, Garancis JC, Abramoff P) Reg Immunol 1988;1(2):119-27 |
| 1 | Cellular immune response to viral peptides in patients exposed to HIV. (Ahearne PM, Matthews TJ, Lyerly HK, White GC, Bolognesi DP, Weinhold KJ) AIDS Res Hum Retroviruses 1988 Aug;4(4):259-67 30 Citations |
| 1 | Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. (Goldman JM, Gale RP, Horowitz MM, Biggs JC, Champlin RE, Gluckman E, Hoffmann RG, Jacobsen SJ, Marmont AM, McGlave PB) Ann Intern Med 1988 Jun;108(6):806-14 777 Citations |
| 1 | Elimination of clonogenic malignant human T cells using monoclonal antibodies in combination with 2'-deoxycoformycin. (Schwartz CL, Minniti CP, Harwood P, Na S, Banquerigo ML, Strauss LC, Kurtzberg J, Smith SD, Civin CI) J Clin Oncol 1987 Dec;5(12):1900-11 5 Citations |
| 1 | HTLV-III serology in hemophilia: relationship with immunologic abnormalities. (Gill JC, Menitove JE, Anderson PR, Casper JT, Devare SG, Wood C, Adair S, Casey J, Scheffel C, Montgomery RR) J Pediatr 1986 Apr;108(4):511-6 11 Citations |
| 1 | Development of a simplified counterflow centrifugation elutriation procedure for depletion of lymphocytes from human bone marrow. (Noga SJ, Donnenberg AD, Schwartz CL, Strauss LC, Civin CI, Santos GW) Transplantation 1986 Feb;41(2):220-9 35 Citations |
| 1 | Inherited absence of OKT4 lymphocyte antigen in a chronically transfused patient with homozygous sickle cell disease. (Gill JC, Maples J, Nikaein A, Kirchner P, Lockhart D, Snyder AJ, Montgomery RR, Casper JT) J Pediatr 1985 Aug;107(2):251-3 1 Citation |
| 1 | Effects of neuraminidase on the regulation of erythropoiesis. (LaRussa VF, Sieber F, Sensenbrenner LL, Sharkis SJ) Blood 1984 Apr;63(4):784-8 4 Citations |
| 1 | T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates. (Menitove JE, Aster RH, Casper JT, Lauer SJ, Gottschall JL, Williams JE, Gill JC, Wheeler DV, Piaskowski V, Kirchner P, Montgomery RR) N Engl J Med 1983 Jan 13;308(2):83-6 207 Citations |
| 1 | Pharmacological modification of immunoregulatory T lymphocytes . II. Modulation of T lymphocyte cell surface characteristics. (Birch RE, Rosenthal AK, Polmar SH) Clin Exp Immunol 1982 Apr;48(1):231-8 39 Citations |
| 1 | Genetic control of the immune response to myoglobin. VI. Inter-site influences in T-lymphocyte proliferative response from analysis of cross-reactions of ten myoglobins in terms of substitutions in the antigenic sites and in environmental residues of the sites. (Atassi MZ, Yokota S, Twining SS, Lehmann H, David CS) Mol Immunol 1981 Oct;18(10):945-8 21 Citations |
| 1 | Genetic control of the immune response to myoglobin. IV. Mouse antibodies in outbred and congenic strains against sperm-whale myoglobin recognize the same antigenic sites that are recognized by antibodies raised in other species. (Twining SS, David CS, Atassi MZ) Mol Immunol 1981 May;18(5):447-50 52 Citations |
| 1 | The effect of cyclosporin A on periodontal disease in rats monoassociated with Actinomyces viscosus Ny 1. (Guggenheim B, Gaegauf-Zollinger R, Hefti A, Burckhardt JJ) J Periodontal Res 1981 Jan;16(1):26-38 12 Citations |
| 1 | Genetic control of immune response to sperm whale myoglobin in mice. II. T lymphocyte proliferative response to the synthetic antigenic sites. (Okuda K, Twining SS, David CS, Atassi MZ) J Immunol 1979 Jul;123(1):182-8 111 Citations |
| 1 | Genetic control of immune response to sperm whale myoglobin in mice. I. T lymphocyte proliferative response under H-2-linked Ir gene control. (Okuda K, Christadoss PR, Twining S, Atassi MZ, David CS) J Immunol 1978 Sep;121(3):866-8 67 Citations |
| 1 | The effect of cyclosporin A on dental caries in rats monoassociated with Actinomyces viscosus NY 1. (Guggenheim B, Hefti A, Burckhardt JJ) Adv Exp Med Biol 1978;107:293-301 1 Citation |
